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General Introduction 
1. INTRODUCTION 
Tissue engineering is the field of functional restoration of tissue structure and physiology 
for impaired or damaged tissues. The three key ingredients for tissue engineering are signals 
for morphogenesis, stem cells responding to these morphogens, and a scaffold to represent the 
extracellular matrix (ECM) (Figure 1).1  
Tissue engineering procedures have been developed for many tissues and organs such as 
bone, heart, liver, and kidney. In recent years, researchers have also isolated cells from 
postnatal dental pulp, and found that these populations exhibited the two basic properties of 
stem cells, i.e., (1) self-renewal and (2) multilineage differentiation.3-5 This fact provides the 
possibility to repair damaged teeth with the patient’s own tissue, when dental tissue 
engineering procedures can be developed. In the next chapters, attention is given to the 
necessary morphogens, cells, scaffolds, and methods to develop such tissue engineering 
procedures. 
  
 
Figure 1: The key elements of tissue engineering and dentin regeneration. The triad consists 
of stem cells, a scaffold and signals of morphogens.2 
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2. MORPHOGENS 
Morphogens are inductive signals that function as growth/differentiation factors. The 
morphogenetic signaling networks exhibit redundant and reiterative properties, each with 
distinct temporal and spatial expression during initiation, patterning formation and 
morphogenesis, and cytodifferentiation.6 Although many morphogens are involved in 
embryonic tooth development, bone morphogenetic proteins (BMPs) appear to be sufficient 
for tooth regeneration in adults.7 
 
2.1 Bone Morphogenetic Proteins 
In 1965, demineralized bone matrix was discovered to induce ossification in intramuscular 
sites in rabbits.8 The responsible molecule was found to be a protein called bone 
morphogenetic protein.9 Today we know that the human genome encodes 20 BMPs.1 BMPs 
are dimeric molecules critically dependent on the single intermolecular disulfide bond for 
biological activity. The monomeric subunit has about 120 amino acids, including seven 
conserved cysteine residues. The BMP family can be divided into four distinct subfamilies: 
first, BMP2 and 4; second, BMP3 and 3B, the latter also known as growth/differentiation 10 
(GDF10); third, BMP5, 6, 7, and 8; and fourth, GDF5, 6, and 7, also known as cartilage-
derived morphogenetic protein 1, 2, and 3. BMP1 is not a member of the BMP family but 
rather a metalloprotease involved in the proteolytic processing of soluble procollagen.10,11  
 A single recombinant BMP can have pleiotropic effects on different steps in bone 
morphogenesis depending on its concentration: femtomolar concentrations promote 
chemotaxis; high concentrations promote mitogenesis and differentiation.1 The BMPs play 
pivotal roles in the development of the brain, eyes, heart, kidneys, skin, bones and teeth. In 
the postnatal skeleton, BMPs are intimately associated with the collagenous extracellular 
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matrix and are localized in periosteal cells and in mesenchymal cells of marrow stroma during 
fracture repair.12,13  
BMPs also play a critical role in tooth morphogenesis.7,14 BMP family members are used 
sequentially and repeatedly throughout embryonic tooth development, initiation, 
morphogenesis, cytodifferentiation and matrix secretion. Six different BMPs (BMP2–7) are 
coexpressed temporally and spatially.15 In craniofacial development, they are involved in the 
inductive interactions between dental epithelium and mesenchyme in a stage-dependent, 
reiterative manner. BMP2, 4 and 7 are expressed in dental epithelium, and recombinant 
BMP2 and 4 can be used as a substitute for dental epithelium, to induce odontogenic 
mesenchyme differentiation.10,16 BMPs are also expressed in the enamel knot and there are 
associated with the differentiation of odontoblasts and ameloblasts. BMP2, 4 and 7 signals 
from the enamel knot influence both epithelial and mesenchymal cells and are responsible for 
the maintenance of the enamel knot and for the subsequent morphogenesis of epithelium.6 
These signals also regulate the patterning of the tooth crown by influencing the initiation of 
the secondary knots together with mesenchymal signals such as BMP4.17-19 BMP3 and 7 have 
also been immunolocalized in developing PDL, cementum and alveolar bone.20,21 However, 
BMP2 is localized only in alveolar bone during root morphogenesis.18 A role for BMP3 in the 
cementoblast lineage has been suggested by its localization in root-lining cells.22  
As for in vitro research, BMP2, 4 and 6 have been identified in human primary culture of 
dental pulp cells.23 Ten BMP family members (BMP2, 4, 6, 7 and 8, growth/differentiation 
factor(GDF)1, 5, 6, 7 and 11, and glial cell line-derived neurotrophic factor (GDNF)) have 
been cloned from rat incisor pulp tissue.7,24 Recombinant human BMP2 stimulates 
differentiation of adult pulp cells into odontoblats in monolayer cultures and in three 
dimensional pellet cultures.25,26 Recombinant human BMP2 and 4, and GDF11 soaked in 
agarose beads also stimulated odontoblast differentiation in organ cultures of dental papillae 
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cells.16,27,28 Recombinant human BMP2 and 4, and 7 can induce reparative/regenerative dentin 
formation in vivo.29-32 BMP-induced formation of tubular dentin is critically dependent on the 
scaffold. Odontoblast differentiation and tubular dentin formation were seen directly on a de-
mineralized dentin matrix, which was inactivated by 4M guanidine hydrochloride extraction 
of BMPs.33 
BMP signaling networks are complex during morphogenesis. Three levels by which BMP 
signaling pathways are regulated can be distinguished: intracellular domains, membrane site, 
and extracellular sites. The BMP antagonists noggin, chordin, follistatin, FSRP, DAN, 
Cerberus and Gremlin modulate the bioavailability of the morphogen.34 Two transmembrane 
receptors, type I and type II with serine–threonine kinase activity, are expressed in dental 
pulp.35-38 BMP signals are transduced from the plasma membrane to the nucleus through a 
limited number of Smad proteins, receptor-activated Smads (R-Smads), common mediator 
Smads (co-Smads) and inhibitory Smads (I-Smads). Many Smad-interacting proteins have 
been detected and determine the outcome of the signaling.39 The BMP signals are frequently 
present for communication and signaling between epithelium and mesenchyme. The same 
signals in different tissues and at different times result in various cellular responses, because 
the history of the cells is determining their competence to respond to the signals.6 
 
2.2 Transforming Growth Factor Beta 
Transforming Growth Factor Beta (TGF-β) was discovered as a product of murine sarcoma 
virus transformed cells.40 In mammals there are three main types (TGF-β1 to 3), all showing 
similar activities in vitro though with some quantitative differences. The effect of TGF-β is 
dependent on cell type, differentiation stage, growth conditions and the presence of other 
growth factors.41,42  
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TGF-β molecules are involved as key participants in odontoblast differentiation and dentin 
mineralization. Differentiated odontoblasts secrete and deposit TGF-β into the dentin matrix, 
and then respond to it in an autocrine action.43 Most studies so far focused on the function of 
TGF-β1 because of its higher expression compared with TGF-β2 and 3. TGF-β1 is known to 
stimulate the synthesis of extracellular matrix and initiate odontoblast differentiation in vivo 
and in vitro.44 Further, teeth contain collagen type I, as well as non-collagenous proteins such 
as osteocalcin (OC) and dentin sialoprotein (DSP). The expression of these matrices is 
regulated by TGF-β1. Odontoblasts and dental pulp cells show the presence of TGF-β 
receptors I and II.45 Activation of TGF-β1 expression in sub-odontoblast cells after injury has 
been suggested to be associated with a differentiation pathway leading to odontoblast-like 
cells.46 The regulatory mechanisms of TGF-β1 as an external stimulus may be due to 
upregulating the secretion of extracellular matrix (ECM) by odontoblasts, and mitogenic 
ability to dental pulp cells in vitro and in vivo.47-49 Recent results have also confirmed that 
TGF-β1 could induce the expression of an odontoblast-like phenotype and the formation of 
dentin-like structures in dental pulp cells.48,50  
 
2.3 Dentin Sialophosphoprotein 
Odontoblasts and dental pulp cells synthesize and secrete several collagenous and non-
collagenous proteins (NCPs) to form a unique dentin ECM. Dentin sialophosphoprotein 
(DSPP), the major NCP in dentin, is a phosphorylated parent protein that is cleaved post-
translationally into two products: dentin sialoprotein (DSP) and dentin phosphoprotein 
(DPP).51,52 DSP and DPP contain high levels of carbohydrate and sialic acid as well as 
aspartic acid and phosphoserine, suggesting a function related to dentin mineralization and 
mineral nucleation.53 DPP appears to be secreted via odontoblastic processes to the 
mineralization front. DPP binds to collagen and plays important roles for the nucleation and 
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modulation of hydroxyapatite crystal formation.58 DSP in dentin and bone is very similar in 
nature but different in quantity, as expression in bone is 400 times lower.55 The function of 
DSP is largely unknown. 
Studies have shown that DSPP is expressed predominantly in odontoblasts, transiently in 
preameloblasts, and at a low levels in bone.54,55 This suggests that the functional role of DSPP 
is mainly involved in tooth formation and mineralization. DSPP is also regarded as the 
specific marker for odontoblasts. The spatial-temporal expression of DSPP is largely 
restricted during differentiational stages of dental cells, and plays a vital role in tooth 
development. The dentin of DSPP knockout mice shows dentinogenesis imperfecta and dentin 
dysplasia.56,57  
 
2.4 Dentin Matrix Protein 1 
Dentin matrix protein 1 (DMP1), a non-collagenous protein expressed in mineralized 
tissues, is an acidic phosphorylated extracellular matrix protein originally cloned from the 
mineralized dentin matrix.59 DMP1 has recently been proposed to belong to a group of 
proteins called SIBLINGs, for small, integrin-binding ligand, N-linked glycoproteins. The 
members of this family also include bone sialoprotein, osteopontin, osteocalcin, osteonectin, 
and dentin sialophosphoprotein. These proteins are known to have an important role in matrix 
mineralization through the regulation of crystal size and morphology.58,60,61 However, Dmp1 
knockout mice have no major phenotypic abnormality in dentin and bone during early 
development. Only with progression of age, defects in bone an dentin are noted. In other 
words, these results suggest that DMP1 might be involved in the late development of bone 
and dentin.62  
Apart from its role in development, DMP1 has a putative function in modulating gene 
expression. DMP1 is an essential factor in the terminal differentiation of mesenchymal stem 
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cells. DMP1 is able to upregulate the expression of specific marker proteins in cells of the 
osteoblast and odontoblast lineage, such as OC, ALP and DSPP, and can enhance the 
mineralization process. Conversely, blocking translation of DMP1 by antisense techniques 
inhibited the expression of these genes and the mineralization process.63 More recently, 
DMP1 has been shown to be involved in more complex biological processes. DMP1 can be 
localized in the nucleus during early differentiation of odontoblats, and function as a 
transcriptional regulator of the DSPP gene by binding to the DSPP promoter to activate its 
transcription.64 Moreover, DMP1 could act as a morphogen on dental pulp stem cells, and 
induce cytodifferentiation of these cells into odontoblasts.65  
 
3. DENTAL PULP STEM CELLS 
3.1 Adult Stem Cells 
Pluripotent stem cells can be isolated from the embryonic inner cell mass. However, ethical 
concerns about the requirement of human embryos and the potential danger of teratoma 
formation, have contributed to the limited use of these cells. In the adult organism, most 
tissues generally contain a small subpopulation of cells, adult stem cells, with the innate 
ability to maintain a stem-cell pool by self-replication, and generate more committed 
progenitors.66 Adult stem cells are known to be present in bone marrow, pancreas, liver, skin, 
etc.67-69 Moreover, they also have been isolated from other adult tissues of which previously 
was thought no self-repair was possible, such as the brain.70 Stem cells are relatively 
quiescent, yet respond strikingly to tissue damage.71  
When stem cells were first discovered, scientist generally accepted that the differentiation 
potential of adult stem cells was restricted to the tissues in which they resided. Later, more 
and more evidence supported that they could even differentiate into specific cell types of non-
related tissues. This property is called “plasticity” or “transdifferentiation”.72-76  
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3.2 Dental Pulp Stem Cells 
3.2.1 Stem Cell Properties 
  When dental pulp tissue is injured and exposed, damaged odontoblasts degenerate and are 
replaced by undifferentiated mesenchymal cells that migrate to the injured site from the 
deeper regions of the pulp tissue. These cells differentiate into new odontoblasts, and produce 
so-called reparative dentin.77,78  
  As pioneers in the field, Gronthos et al. have isolated odontogenic stem cell populations 
from postnatal human dental pulp, and found that these populations shared the two basic 
properties of stem cells, (1) self-renewal and (2) potency for multilineage differentiation. 
Transplantation of human dental pulp stem cells (DPSCs) in immunocompromised mice 
resulted in the formation of a dentin-pulp-like complex structure.3-5 DPSCs appeared also to 
be able to differentiate into adipocytes, neural-like cells, myocytes, and chondrocytes when 
suitable inductions were used.4,5,79,80  
   In contrast to bone marrow stem cells (BMSCs), dental stem cells did not form 
haematopoietic marrow or adipocytes at the transplantation site.3 When the gene expression 
profile of human dental pulp stem cells was compared with bone marrow stromal stem cells, a 
few genes, including collagen type XVIII α1, insulin-like growth factor-2 (Igf2), discordin 
domain tyrosine kinase 2, and cyclin-dependent kinase 6, were more highly expressed in 
DPSCs. Furthermore, the study revealed that the expression levels for several genes, which 
belong to cell division, cell signal, cell structure, and metabolism, were regulated differently 
between both cell types, upon prolonged culturing.81,82 
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3.2.2 Subpopulations of DPSCs 
   There is ample evidence showing that DPSCs have the potential to be applied for tissue 
engineering. However, the behavior of various types of DPSCs is quite different from each 
other, even when derived from the same source. The majority of the progeny (80%) derived 
from single colonies was only able to proliferate for less than 20 population doublings. Only 
67% of the more highly proliferative single-colony-derived DPSC strains formed the same 
amount of dentin as multi-colony derived dental pulp cells on a HA/TCP carrier in vivo.3,4 
These results suggest a hierarchy of subpopulations in adult dental pulp, including a minor 
population of self-renewing, highly proliferative, multipotent stem cells, among a larger 
compartment of perhaps more committed progenitors.4 The opinion of a hierarchy of cellular 
differentiation has also been found in other stem cell populations, such as in BMSCs.83 
   STRO-1 is the most extensively used antibody that appears to recognize stage-and/or 
lineage-specific stromal antigens. The monoclonal antibody STRO-1 reacts with an 
unidentified cell surface antigen expressed by a minor subpopulation of BMSCs.84,85 Some 
data demonstrates that the STRO-1 fraction in adult bone marrow are eventually the stem 
cells with the capacity for differentiation into smooth muscle cells, adipocytes, osteoblasts 
and chondrocytes.84-87 Previous studies showed that human dental pulp also contained STRO-
1 positive cells. Like in other adults tissues, these cell populations always existed in the stem 
cell niches, identified as highly vascularized sites.4,5,88,89 The STRO-1 positive cells could be 
purified from dental pulp cells by fluorescence-activated cell sorting (FACS) or magnetic-
activated cell sorting (MACS).89-91 Although STRO-1 selection usually is aimed at human cell 
populations, a recent study also showed that rat derived dental pulp cells contained STRO-1 
positive cells.92  
  Other cell markers have also been explored to sort functional subpopulations from dental 
pulp cells, such as CD146 which is expressed by endothelial cells, smooth muscle cells and 
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pericytes, α-smooth muscle actin which is expressed by smooth muscle cells and pericytes, 
and a pericyte-associated antigen (3G5). Transplantation of expanded CD146 positive cells 
with hydroxyapatite/tricalcium phosphate scaffold resulted in ectopic dentin formation.89 
Furthermore, a side population could be isolated from dental pulp based on the exclusion of 
the DNA binding dye (Hoechst 33342) by FACS. These subpopulation cells maintained the 
self-renewal capacity, and multipotency for dentinogenesis, chondrogenesis, adipogenesis, 
and neurogenesis, and stimulated the reparative dentin formation.80,93,94 
 
4. SCAFFOLDS 
   Scaffolds provide a physicochemical and biological three-dimensional micro- environment 
for cell growth and differentiation, promoting cell adhesion, and migration. The scaffold can 
also serve as a carrier for the morphogen. Scaffolds should be effective for the transport of 
nutrients, oxygen, and waste. Preferably, a scaffold should be gradually degraded and 
replaced by the regenerated tissue, while retaining the features of the final tissue structure. 
Furthermore, it should be biocompatible, non-toxic, and have proper mechanical strength.95 
Various scaffold materials have been employed in recent studies on tooth regeneration, 
ranging from long-lasting porous hydroxyapatite ceramics, naturally occurring molecules 
capable of degrading at intermediate duration (e.g. collagen and chitosan), to relatively short-
lasting polymers such as polyglycolic acid (PGA), poly(L-lactic acid) (PLA) and poly(D,L-
lactic-co-glycolic acid) (PLGA).96-98 
Natural polymers, such as collagen and fibronectin, have the advantage of good 
cytocompatibility and bioactivity. Fibronectin can mediate the binding of signaling molecules 
and play a role in the interaction between extracellular matrix and cells, to reorganize the 
cytoskeleton of polarizing preodontoblasts in the pulpal wound healing process.99 The RGD 
site in fibronectin is critical for cell adhesion.100 Collagen shares similar chemical and 
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biological characteristics compared to natural tissues, and has a low antigenicity. Collagen 
type I is the predominant component of the dentin matrix as well as the dental pulp. The 
presence of collagen type I in dentin is considered to offer initiation sites for calcification.101 
Collagen also allows the arrangement of preodontoblasts, and binds newly formed 
odontoblasts to pulp tissue, supporting a reparative dentinogenesis framework.102 Therefore, 
many researchers have concentrated on this type of scaffold material. Finally, collagen has 
been used as a capping material to achieve the regeneration of the dentin-pulp complex.103,104  
Synthetic extracellular matrices have also been developed as potential scaffolds for 
reparative dentinogenesis.105 Alginate hydrogel facilitates pulpal wound healing and can 
deliver growth factors, like TGFβ1 to enhance the natural regenerative capacity of the dental 
pulp.106 Mineral trioxide aggregate (MTA), a powder consisting of fine hydrophilic particles 
of tricalcium silicate, tricalcium aluminate, tricalcium oxide, and silicate oxide has recently 
been investigated as a potential restorative material. MTA sets in the presence of moisture, 
prevents microleakage, is biocompatible, and promotes reparative dentin formation.107  
Calcium phosphate ceramic is also a generally used material for hard tissue regeneration 
because of its highly biocompatible nature and the ability to support the differentiation of 
osteogenic cells. In dentistry, calcium phosphate-related materials are widely applied as pulp-
capping agents.108 Moreover, calcium phosphate ceramics have been used to manufacture 
dental implants.109 Especially, porous ceramics consisting of hydroxyapatite (HA) and 
tricalcium phosphate (TCP), have been utilized for ectopic bone formation. These also show 
clear hard tissue formation in vivo when seeded with DPSCs, and exhibited abundant 
ingrowth of tissue and vasculature.3-5,104  
Titanium is a highly biocompatible and mechanically strong material. These properties 
make titanium one of the most popular materials for bone regeneration and dental 
implantation.110,111 Although non-degradable, porous and fibrous titanium scaffold designs 
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harbor great potential for hard tissue engineering purposes. Titanium fibrous mesh supported 
the differentiation of DPSCs, and induced the formation of calcified nodules in vitro.92,112 
Furthermore, the beneficial in vivo behavior of this scaffold was also confirmed.113 
An alternative to the use of a synthetic matrix is the use of three-dimensional cultures with 
an assembly of endogenous extracellular matrix. Recently, the scaffold-free culture system 
named “cell-pellet engineering” has been developed.26,114 This system involves formation of 
cell pellets or aggregates, allowing for three-dimensional interaction between the neighboring 
cells favoring the synthesis of extracellular matrix in the pellet. 
 
5. REGENERATION OF DENTIN-PULP COMPLEX 
The dentin-pulp complex protects teeth from caries and trauma by maintaining the 
hydration of the extracellular matrix. The goal of endodontics and conservative dentistry is to 
restore or regenerate the dentin-pulp complex to maintain the vitality and function of teeth. 
The ideal therapy for repairing a pulp wound would be to stimulate proliferation of dental 
pulp stem cells, and induce their differentiation into odontoblasts to enhance healing potential 
and rapid dentin formation.10 To date, different approaches have been developed, including 
stem cell-based therapy, and gene therapy. 
 
5.1 Stem Cell Therapy 
    For cell therapy, stem cells can be derived from various tissues. The choice of the tissue 
source is governed by availability, as well as by the degree of characterization of the 
stem/progenitor cells in terms of surface markers and differentiation pathway. The generally 
weak immunogenicity of mesenchymal stem cells has broad advantages and implications for 
allogeneic cell therapy.10  
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   Dentin repair/regeneration in adult animals takes place through the activity of odontoblasts 
that differentiate from a stem/progenitor cell population existing in postnatal dental pulp 
tissue. Highly proliferative dental pulp stem cells (DPSCs) have the ability to generate a 
dentin/pulp-like complex including a mineralized matrix when grafted into the dorsal surface 
of immunocompromised mice.3-5,104 Complex tooth-like structures have been generated by 
seeding DPSCs onto biodegradable polymer scaffolds.96-98  
 Using the cell pellet engineering approach, the autogenous transplantation of DPSCs onto an 
amputated pulp stimulated reparative dentin formation.26 DPSCs pellets, when transplanted 
into the renal capsule of immunocompromised mice, resulted in the generation of a regular-
shaped dentin-pulp complex containing distinct dentinal tubules and predentin.114 This 
method avoids several obstacles associated with biodegradable scaffolds and provides some 
significant advantages in dental tissue engineering. First, cell-cell and cell-matrix interactions 
in cell pellet are more sufficient and original than those in scaffold-based tissue engineering. 
Second, the cell movement and selective cell adhesion inside the pellets are more native than 
those in scaffolds. Additionally, because there are no artificial materials used, host response to 
graft material can be avoided.115 However, the optimization of this pellet culture system still 
needs further investigations, including the in vivo culture time, pellet size, right culture 
medium, and so on.  
 
5.2 Gene Therapy 
  In tissue engineering there is always the need for the application of morphogens. However, 
there are some limitations for local delivery of proteins, including short half-life, large dose 
requirement, high cost, the need of repeated applications, and poor distribution.116 Gene 
therapy is an alternative approach to conquer the limitations of protein therapy. Gene therapy 
is a means of delivering genes for growth factors, morphogens, transcription factors, 
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extracellular matrix molecules, etc, locally to somatic cells of individuals with a resulting 
therapeutic effect. The genes applied can stimulate or induce natural biological processes by 
expressing bioactive molecules that are involved in regenerative response for the tissue.117 
Precise delivery and efficient transfer of genes into target tissue cells, appropriate gene 
expression at required times and levels, and minimal toxicity in vivo are essential for a 
successful gene therapy. Both in vivo and an in vitro approaches can be used for gene therapy 
(Figure 2). The choice for an in vivo or in vitro approach depends on morphological and 
physiological characteristics of target tissue, the vector used, nature of affected disease and 
the safety of the procedure.118 
  Either viral or non-viral vectors are used to enable the cellular up-regulation and expression 
of genes. Viral vectors are genetically altered to eliminate the ability of causing disease, 
without losing infectious capacity. The viruses can replicate genes of interest together with 
their own genome through the use of the host cell genetic machinery. At present, gene vectors 
have been developed from adenovirus, retrovirus, adeno-associated virus, herpes simplex 
virus and lentivirus.10,118 Non-viral delivery systems have also been described, e.g. plasmids, 
cationic liposomes, DNA-ligand complex, gene gun, electroporation, and sonoporation, to 
address safety concerns such as immunogenicity and insertional mutagenesis.119,120 
 
Figure 2: Two main strategies for pulp therapy to regenerate dentin: in vivo and ex vivo 
methods by application of BMP gene2 
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5.2.1 In Vivo Gene Therapy 
  For the in vivo approach, the gene is delivered into the blood or target tissue by injection or 
implantion.118 Recently, genes for vascular endothelial growth factor (VEGF), angiopoietin, 
fibroblast growth factor (FGF), and hepatocyte growth factor (HGF), all have been directly 
transfected in tissues. The efficacy for stimulating angiogenesis to improve cardiac and limb 
vascular insufficiency has been demonstrated preclinically.120 
  BMPs are important growth/differentiation factors in dental tissue engineering. Both viral 
and non-viral gene transfer have been used to express genes, and produce endogenous BMPs 
in pulp tissue. BMP7 protein therapy is known to be effective to induce 
reparative/regenerative dentin, but not in inflamed pulp tissue.31 However, a recombinant 
adenovirus containing the full-length BMP7 gene induced a small amount of dentin formation 
after direct transduction in experimentally inflamed pulp.121  
Although the efficiency of gene delivery is relatively low, non-viral approaches have also 
been used in pulp tissue. There are some advantages for non-viral gene therapy, such as stable 
production of plasmids with a high level of purity, easy manipulation, minimal risk of 
replication or incorporation, and weakly immunogenity.27,119,122 The GDF11 plasmid was 
transfected efficiently by electroporation into DPSCs to induce the expression of DSPP, and 
this approach resulted in some level of reparative dentin formation.27 A study using 
ultrasound-mediated GDF11 gene transfer together with microbubbles also induced 
differentiation of pulp stem cells into odontoblasts in vitro, and gave a more homogenous and 
complete reparative dentin formation in vivo.122 
  
5.2.2 In Vitro Gene Therapy 
  The in vitro gene therapy approach involves the genetic manipulation or decoration of 
somatic cells in vitro, which are subsequently transplanted to the regeneration site. For 
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example, mesenchymal cells have been transfected with morphogens or growth factors such 
as BMPs genes, and implanted into a defect site in cartilage or bone.118,123124 The cells play a 
role not only in the repair process, but also in secretion of growth factors to stimulate host 
cells at the local site.125  
Some studies have shown that in vivo gene therapy is ineffective for reparative dentin 
formation, if there is a severe inflammation and only few stem/progenitor cells are present in 
the pulp tissue.121 An alternative in vitro gene therapy approach, using the autogenous 
transplantation of BMP gene-transfected DPSCs into the exposed pulp, might be clinically 
useful. This approach can initially induce osteodentin. It can be followed by a lasting tubular 
dentin formation in the exposed pulp by transplantation of GDF11-transfected pulp 
stem/progenitor cells in pellet.27 The transplantation of dermal fibroblasts, transfected with 
BMP7 gene mediated by adenoviral vector, also was shown to induce reparative dentin 
formation in the exposed pulp with reversible pulpitis.121 BMP gene decorated cells can 
directly contribute to reparative/regenerative dentin formation, and the various growth/ 
differentiation factors retained in the matrix of the transplantation might be gradually released 
and induce host pulp cells differentiation. The great potency of the BMP genes to provoke 
differentiation of pulp cells, demonstrates the utility of in vitro gene therapy in clinical 
treatment. The present challenges for gene therapy will be to demonstrate that gene therapy 
can provide cost-effective and safe long-term treatments for conditions that would otherwise 
lead to significant pulp necrosis.119 
Furthermore, recent studies have revealed that adult fibroblasts can be driven into 
functional pluripotent stem cells by introducing four factors: Oct3/4, Sox3, c-Myc, and 
Klf4.126,127 Therefore, it seems possible to obtain embryonic dental epithelial/mesenchymal 
cells and initiate a bioengineered odontogenesis by delivering specific genes or growth factors 
into adult dental cells.  
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6. PROSPECTS 
With the improvement of dental care, deciduous (primary) and permanent (secondary) teeth 
can be preserved much longer than before. However, trauma and old age still can cause tooth 
loss. Although tooth-loss is not a lethal disease, it influences mastication and esthetics, and 
decreases the quality of life of individuals.128 Stem cell-based dental tissue engineering may 
be the answer to one day achieve a “tertiary dentition”. Further systematic studies with 
stem/progenitor cells, morphogens, and novel scaffolds are required for such regenerative 
dental tissue engineering.  
 
7. OBJECTIVES OF THIS THESIS  
In this thesis, the following research questions will be addressed: 
1. Can a more homogeneous cell subpopulation be sorted from rat dental pulp cells using 
STRO-1 selection? 
2. What is the multilineage differentiation potential of STRO-1 selected rat dental pulp 
stem cells in vitro? 
3. Do STRO-1 selected dental pulp stem cells have the ability for hard tissue formation  
in vivo, when seeded in porous HA/TCP ceramic scaffolds? 
4. What is the influence of adenoviral-mediated Bmp2 transfection on dental pulp stem 
cells in vitro? 
5. How is the in vivo behavior of adenoviral-mediated Bmp2 transfected dental pulp stem 
cells? 
6. Can calcium phosphate nanoparticles be applied as a non-viral vector for Bmp2 
transfection into dental pulp stem cells?  
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1. INTRODUCTION 
Several studies have isolated the highly proliferative dental pulp cells (DPCs) from adult 
pulp tissue of various species, and have shown the potential of cells to differentiate towards 
odontoblasts and mineralize in vitro.1-4 Recent studies proved the existence of stem cells in 
human dental pulp tissue, and characterized the properties of such cells.5,6 The dental pulp 
stem cells (DPSCs) demonstrated self-renewal capability, and could differentiate towards 
odontoblasts which formed a pulp-dentin complex in vivo when transplanted into 
immunocompromised mice, even after long-term cryopreservation.7 A recent study showed 
that DPSCs, when treated with conditional medium from tooth germ cells, could differentiate 
into regular-shaped dentin-pulp complexes.8 Furthermore, DPSCs were also capable of trans-
differentiating into adipocytes and neural-like cells by conditional inductions.6,9 However, the 
behavior of DPSCs was quite variable, even for cells derived from the same source. These 
results suggest a hierarchy of progenitors in adult dental pulp, including a minor population of 
self-renewing, highly proliferative, multipotent stem cells, among a larger compartment of 
perhaps more committed progenitors. The opinion of a hierarchy of cellular differentiation has 
also been found in other stem cell populations, such as in bone marrow stem cells (BMSCs).10  
Although the isolation of DPSCs can provide a potential cell source for hard tissue 
engineering in the future, previous in vivo research has showed variable results, which results 
in a low therapeutic potential.5,6  Fluorescence-activated cell sorting (FACS) with antibodies 
against specific cell receptors can form a more standardized way of retrieving and culturing 
DPSCs. 
The monoclonal antibody STRO-1 reacts with an unidentified cell surface antigen 
expressed by a minor subpopulation of BMSCs. Some data demonstrate that the STRO-1 
fraction in adult bone marrow is eventually stem cells with the capacity for differentiation into 
smooth muscle cells, adipocytes, osteoblasts and chondrocytes.11-14 Previous studies also 
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demonstrated that DPSCs contained a STRO-1 positive cell population and showing 
positively of 9% in DPSCs.6,9 A STRO-1 positive populations were sorted from human 
DPCs.15 Further, recent study showed that also rat derived DPCs contained STRO-1+ cells.16 
In this study, we will investigate if a STRO-1 positive cell population can be isolated from rat 
DPCs, and if, such still exhibits odontogenic potential.  
In the current study, we hypothesize that a STRO-1 positive cell sorting can result in a 
more homogenous cell population, which will harbor an improved odontogenic differentiation 
capacity compared to STRO-1 negatives or the non-sorted cell population. 
 
2. MATERIALS & METHODS 
2.1 Cell Culture 
The animal ethics committee of the Radboud University Nijmegen Medical Centre 
approved this research, and all national guidelines were taken into consideration. Maxillary 
incisors of Wistar rats (40 days old, male) were dissected, and primary rat dental pulp cells 
were acquired from these dental pulp tissues.16  
 
2.2 Fluorescence-activated Cell Sorting  
For cell sorting experiments, 10 x 106 dental pulp cells of the third passage were 
resuspended in 1 mL PBS/1%BSA and preincubated for 15 min on ice. Subsequently, cells 
were incubated with 200μL PBS/1%BSA with STRO-1 monoclonal antibody (20 μg/mL, 
R&D Systems, Minneapolis, MN) for 15 min on ice. After centrifugation and washing, 
samples were incubated in 200μL PBS/1%BSA with phycoerythrin (PE)- conjugated goat 
anti-mouse IgG antibody (1:50; Sigma) for an additional 15 min on ice, washed, resolved, and 
kept on ice until sorting. Cells were sorted using a FACStar Plus flow cytometer (Beckton 
Dickinson & Co., Mountain View, CA). The samples were maintained at 4℃ through the 
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cell-sorting procedures. Positivity was defined as a level of fluorescence greater than 99% of 
the blank (without 1st and 2nd antibody reaction) and negative (without 1st antibody reaction) 
controls. STRO-1 positive (+) cells were collected and expanded. Non-sorted cells and 
STRO-1 negative (-) cells were also used as controls for osteogenic cell culture.  
To prove the efficacy of the applied FACS sorting, three types of cells obtained (STRO-1+ / 
STRO-1- / non-sorted cells) were also assessed for STRO-1 positive cell content by 
immunofluorescence. Subsequently, the three cell populations were seeded onto 24-well 
plates or on coverslips (Thermanox®) for scanning electron microscopy (SEM) analysis at a 
density of 2 x 104 cells/well in α-MEM supplemented with 10% FCS, 10 mM sodium β-
glycerophosphate, 10-8 M dexamethasone, L-ascorbic acid (50μg/mL), and gentamycin 
(50μg/mL). Culture medium was changed at 2- to 3- day intervals. 
 
2.3 Cell Proliferation, Alkaline Phosphatase and Calcium Content 
On day 1, 2, 4, 8, 16 and 24, the proliferation rates of cells, as measured by total DNA 
content, were assessed with a PicoGreen dsDNA quantification kit (Molecular Probes, 
Leiden, The Netherlands). The same supernatants as used above were also used to measure 
alkaline phosphatase (ALP) activity. Twenty μL of 0.5 M 2-amino-2-methyl-1-propanol 
buffer was added to 80 μL of the samples or standards,. Next, 100 μL of substrate solution ( 
p-nitrophenyl phosphate) was added and the mixtures were incubated at 37℃ for 1 h. ALP 
activity was measured at 405nm, using an ELISA microplate reader (Bio-Tek Instruments 
Inc., USA). On day 8, 12, 16 and 24, the calcium content of the samples was measured by the 
o-cresolphthalein complexone (Sigma) method.16  
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2.4 Scanning Electron Microscopy 
On day 8, 12, 16 and 24, samples were rinsed with filtered PBS, and fixed in 2% 
glutaraldehyde for 5 min. They were then dehydrated in graded series of ethanol, and dried in 
tetramethylsilane (Merck, Germany). Gold was sputtered on the samples just before SEM 
analysis. The specimens were examined with a JEOL 6310 Scanning Electron Microscope 
.  
2.5 Real-Time Quantitative PCR 
On day 1, 8 and 16, total RNA of every sample was prepared with RNEasy kit (Qiagen, 
The Netherlands). Isolated RNA was measured with the spectrophotometer. One μg RNA was 
used to make cDNA. Five markers monitored the differentiation of cells: ALP, osteocalcin 
(OC), collagen type I (Col I), dentin sialophosphoprotein (DSPP), and dentin matrix protein-1 
(DMP-1). GAPDH was used as house-keeping gene to normalize RNA expression (Table.1). 
Real-time PCR was performed using SYBR Green PCR kit (Eurogentec, Liege, Belgium) and 
controlled in a spectrofluorimetric thermal iCycler® (BioRad, The Netherlands). After the 
real-time PCR run, a Ct-value showed how many PCR cycles were necessary to obtain a 
certain level of fluorescence. Amplification efficiency of different genes was determined 
relative to GAPDH as an internal control (ΔCt = Ct gene – Ct GAPDH). Interested mRNA in 
each sample was calculated by a comparative ΔΔCt (ΔCt gene – ΔCt control ) value method. 
Each sample was assessed in triplicate. 
Table 1:  Rat specific primers for real-time PCR 
 
 Sense primer Antisense primer 
ALP 5’-GCTTCACGGCATCCATGAG- 3’  5’-GAGGCATACGCCATGACGT-3 
OC 5’-GGCTTCCAGGACGCCTACA-3 5’-CATGCCCTAAACGGTGGTG-3’ 
Col I 5’-TGGAATCTTGGATGGTTTGGA-3’ 5’-GCTGTAAACGTGGAAGCAAGG-3’ 
DSPP 5’-CGGTCCCTCAGTTAGTC-3’ 5’-TACGTCCTCGCGTTCT-3’ 
DMP-1 5’- CGTTCCTCTGGGGGCTGTCC -3’ 5’- CCGGGATCATCGCTCTGCATC -3’ 
GAPDH 5’- GAAGGGCTCATGACCACAGT-3’ 5’- GGATGCAGGGATGATGTTCT-3 
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2.7 Statistical Analysis 
Statistical significance was evaluated using one way-ANOVA with post-hoc Tukey testing, 
and P < 0.05 was considered significant. Error bars represent means ± standard deviation 
(SD). 
 
3. RESULTS 
3.1 Isolation of Dental Pulp Stem/Precursor Cells 
Compared with the blank and negative controls, approximately 0.5% of the total dental 
pulp cells from the third passage were sorted as STRO-1+ population (Figure 1 A, B). All 
isolated cells had a typical spindle-shaped morphology with extending cytoplasmic processes, 
and no apparent differences were seen between STRO-1+ and STRO-1- fractions by visual 
inspection. The immunofluorescence results however confirmed the efficacy of the sorting 
process, i.e. much more positively stained cells could be found in STRO-1+ cell population, 
compared to non-sorted cells. For the STRO-1- cell population, positively stained cells were 
almost absent (Figure 1 C-E).     
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Figure 1: Isolation of STRO-1+ dental pulp 
cell population by FACS: (A) The living cells 
were selected for sorting by forward scatter 
(FSC); (B) FACS of STRO-1+ (PE) 
expression cell population showed a 
approximately 0.5% of the total dental pulp 
cell population of the third passage. 
Fluorescent micrographs of three cell 
populations after immunofluorescent 
staining: (C) STRO-1+ group; (D) STRO-1-
group; (E) non-sorted cells (original 
magnification 10 X). 
3.2 Cell Proliferation, ALP Activity, and Calcium Content Measurement 
The cell proliferation rates showed exponential growth of all three populations during 24 
days, although there were some significant differences. Cells of the STRO-1+ and STRO-1- 
fractions grew more rapidly than of the non-sorted cells, especially for STRO-1- population 
(Figure 2 A). Considering ALP activity, all three groups kept increasing during the 24 days of 
incubation, but STRO-1- population always showed significantly lower levels (Figure 2 B). 
The changes of calcium content in these fractions were always reflecting the ALP, and the 
STRO-1- group retained significantly lower values during the 24 days (Figure 2 C). 
A B 
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C 
Figure 2: Growth characteristics of three cell 
populations (A) The proliferation characteristics; 
(B) ALP activity; (C) Calcium content. The bars 
represent the means ± SD (n=6). The STRO-1+ 
group (S+) compared to the STRO-1- group (S-)* 
P<0.05, * * P<0.01; STRO-1+ group compared to 
non-sorted cells (P3): # P<0.05, ## P<0.01 
3.3 SEM Analysis 
On day 8, SEM analysis showed that all cells had spread well on the surface of the cover 
slips. Most of cells were spindle-shaped and interconnected. For the STRO-1+ and control 
cells, a mineralized extracellular matrix was observed on the surface after day 12. On day 24, 
matrix deposition had increased, and numerous calcified nodules were observed. At that time 
some cells were fully covered with mineralized deposits. In contrast, the STRO-1- cells also 
formed a confluent layer, but there was no obvious mineralization visible (Figure 3). 
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Figure 3: Scanning electron micrographs of 
three cell populations on day 24. (A),(B) 
STRO-1+ group; (C),(D) STRO-1- group; 
(E),(F) non-sorted cells. 
3.4 Real-time PCR 
Using quantitative real-time PCR, expression of mRNA for ALP, OC, Col I, DSPP and 
DMP-1 was detected in all three cell populations on days 1, 8 and 16. The mRNA expression 
levels of non-sorted cells on day 1 were selected as baseline control (set as 100%), and were 
subsequently compared to the other groups and days. For ALP, gene expression level in 
STRO-1+ cells was significantly up-regulated at the beginning and down-regulated after that. 
In contrast, ALP expression peaked in non-sorted cells on day 8. For OC and collagen type I, 
gene expression level in STRO-1+ and non-sorted cells kept increasing from day 1 to 8, and 
decreased after that. However, mRNA levels in STRO-1+ cells were significantly higher than 
that in non-sorted cells from day 1 to day 8. The expression of DSPP and DMP-1, two dentin-
specific markers, showed almost similar profiles in STRO-1+ and non-sorted cells. Results 
showed that DSPP and DMP-1 were gradually up-regulated from day 1 to 16, and peaked on 
day 16. STRO-1+ cells also showed significant up-regulation, compared to non-sorted cells. 
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However, for STRO-1- cells, these genes of interest were only expressed at significantly low 
levels, and a completely different profile was formed (Figure 4).  
    
            
 
 
4. DISCUSSION 
DPSCs harbor the capacity to form a dentin-pulp complex in vivo as well as the potential to 
be used in hard-tissue engineering. However, DPSCs acquired by single-colony-derived 
methods always show a hierarchy of differentiation ability and hard-tissue formation.5,6,17 This 
implies that clonogenic methods cannot provide a cell population with standardized 
Figure 4: Representative curves of the mRNA levels of ALP 
(A); collagen type I (B); OC (C); DSPP (D); DMP-1 (E); 
quantified during 16 days. The bars represent the means ± 
SD (n=3). The STRO-1+ group (S+) compared to the 
STRO-1- group (S-): * * P<0.01; STRO-1+ group 
compared to non-sorted cells (P3): # P<0.05, ## P<0.01 
 52
                                                                                                                                     Chapter 2 
differentiation potential to be used in tissue engineering. Therefore, a method is needed to 
isolate appropriate populations of DPSCs.  
Of course, we have to be very cautious in the description of our “unsorted cells”.  Although 
we did not actively select these cells by the FACS technique, they do not fully represent the 
entire pulp tissue either. In fact, they have underwent some sort of sorting, as the cell culture 
process discriminates on adhesion criteria, i.e. non- adherent cells from the pulp were
removed as a result of the culturing. This of course is very similar to the selection criteria that 
have been widely used before, to select differentiating cells from the bone marrow. 
For FACS as a cell separation method, STRO-1 as specific cell receptor was selected in the 
current study because STRO-1 is the mesenchymal stem marker and is also expressed in some 
populations of DPSCs.6,9,15 Successful experiences for using FACS linked with STRO-1 
antibody in BMSCs have been reported.13,14,18 The present study focused on the odontogenic 
potential of the STRO-1+ population, and the difference between STRO-1+ and STRO-1- 
populations in cell phenotype. For the stem cells isolated from dental pulp tissue, these issues 
are still not fully understood.  
Earlier experiments showed that DPSCs, isolated from the pulp of human exfoliated 
deciduous teeth by clonogenic method, exhibited a ~ 9% positively for STRO-1.9 In our 
study, a much lower percentage (0.5%) was positive for STRO-1+ cell population obtained 
from third passage dental pulp cells. This difference can have occurred because we used rat 
material, with a human marker. Still, our p
cell selection was affirmative. Other explana
the cell population was sorted from the com e 
single-colony-derived cell populations. C hich 
necessitate visual inspection and personal selection,5 FACS requires a relatively standardized 
kill and can be more helpful to isolate a stable and homogeneous population. Further, the 
 
ost-selection assessment proved undoubtedly that 
tions for the low number might lie in the fact that 
plete primary culture cells rather than from th
ompared with the clonogenic methods, w
s
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very low percentage of STRO-1+ cells can be due to the long time in primary culture before 
se
tion from BMSCs showed a lack of osteogenic 
po
y, STRO-
1+
he mRNA confirmed the up-regulation of ALP expression in 
ST
lection was applied.11,19 
On the smooth tissue culture surfaces, the ability of cells to form multilayers seems to be 
the basis of mineralization, because single-cell layers cannot produce mineralized matrix.20 
Similar to cells retrieved from bone marrow,12,13 our sorted STRO-1+ rat dental pulp cells 
showed the capacity to form multilayers and mineralized nodules when cultured in 
conditional medium. The STRO-1- popula
tential.21 Our study corroborated such data and also showed that the STRO-1- fraction lack 
of the capability to form mineralized nodules in vitro, although possessing more proliferation 
ability, compared to STRO-1+ and non-sorted cells. This fact can be due to the inverse 
relationship between proliferation and differentiation, i.e. when cells are more proliferative 
then the differentiation of the cells is declined, and vice versa. ALP is a prerequisite for 
functional differentiation of BMSCs, and DPCs in vivo and in vitro.22,23 In our stud
 cells showed outstanding ALP activity, analogous to that of DPCs under the same 
conditions.16 The results of the calcium content measurement mirrored the findings for ALP, 
and were consistent with quantity and scale of mineralized nodules as seen in SEM 
microscopy. These findings suggest that STRO-1+ cells possess the capacity to differentiate 
into odontoblast-like cells in vitro, similar to BMSCs.23 
In the current study, ALP, OC, Col I, DSPP, and DMP-1 were chosen as differentiation 
markers for real-time PCR. T
RO-1+ cells, and reached a peak at day 1. However, the expression of mRNA is always 
prior to protein expression. ALP gene expression was down-regulated in STRO-1+ cells from 
day 1 to day 16. Furthermore, the STRO-1+ cell population, because of its more 
homogeneous stem cell population, would result in more sensitive reaction for odontogenic 
induction, in contrast to peak expression level at day 8 of non-sorted cells. Collagen type I is 
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the predominant collagen in dentin and bone matrix. OC, a non-collagenous protein, is also 
present in dentin and bone matrix. DSPP is the major part of the dentin noncollagenous 
proteins, and plays a crucial role during dentin mineralization.24 DMP-1 is another specific 
protein in dentin, and is a candidate gene for dentinogenesis imperfecta.25  Expression of these 
mRNAs can prove that these cells exhibit odontogenic potential. Our study confirmed that 
STRO-1+ cells possess relatively high expression levels of these genes, and showed the same 
results as previously described for BMSC and primary DPCs.16,26 Interestingly, all the genes 
in
.  
vestigated maintained a significantly low expression level in STRO-1- cell population, 
similar to cells cultured without the conditional medium.15 For the results of real-time PCR, 
the STRO-1+ cell population showed a more sensitive reaction and odontogenic potential 
under conditional induction, compared to the STRO-1- population, which was analogous to 
the primary DPCs.2,16 
BMSC were already confirmed to be heterogeneous,27 and in vitro expanded STRO-1+ and 
STRO-1- cells were shown to have differences in cell-phenotype and capacity for gene 
delivery. The STRO-1+ population from BMSC is more homogenous and therefore a better 
substrate for gene delivery than the STRO-1- population.18 In our study, these two cell 
populations also showed differences in cell growth and odontogenic differentiation, although 
derived from the same primary cell populations. 
Based on our results, we conclude that our hypothesis can only partially be proven. Indeed, 
removal of STRO-1- population was possible in order to obtain a STRO-1+ cell population 
which is more homogenous. This positive cell fraction was capable of differentiating into the 
odontogenic pathway, whereas the negative fraction was not. However, the effect was not 
always advantageous, when compared to non-sorted cells
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1. INTRODUCTION 
Stem cells generally are defined as colony-derived populations, which exhibit capacity for 
self-renewal and differentiation into a variety of tissue lineages.1-3 Stem cells have been found 
in various adult tissues, including bone marrow, neural tissue, muscle, and fat.4-8 Recently, 
stem cells were also found in adult dental pulp cell (DPCs) populations. It was demonstrated 
that the stem cells in DPCs possessed the capacity for multilineage differentiation into cell 
types like osteoblasts, adipocytes, and neural-like cells.9-11 Therefore, DPCs may represent a 
novel cell population that has potential for tissue engineering in the future. 
Some pioneering studies on bone marrow stromal cells (BMSCs) showed that these cells 
were considerably heterogenous in terms of size, morphology, enzyme histochemistry, 
proliferation profile and differentiated potential.12-14 Analogous results were also found in 
DPCs. The behavior of DPCs and BMSCs was quite variable, even for cells derived from the 
same source. This suggests a need for a method that can isolate especially the stem cells 
fraction from the other cells present in dental pulp. The availability of monoclonal antibodies 
recognizing subpopulations is providing means for such selection. STRO-1 is the most 
extensively used antibody, and recognizes cell surface antigen expressed by a small subset of 
mesenchymal stem cells. Previous studies have shown that the enriched STRO-1 positive 
fraction from human bone marrow stromal cells had the capacity for self-renewal and could 
differentiate into smooth muscle cells, adipocytes, osteoblasts and chondrocytes.12,15-17 
Human DPCs also contained STRO-1 positive cells, and these cells had the potential for 
differentiation into osteoblasts and adipocytes.10,18,19 Although STRO-1 selection usually is 
aimed at human cell populations, a recent study also showed that rat derived DPCs contained 
STRO-1+ cells.20 In our previous study, a STRO-1 positive fraction was successfully isolated 
from rat incisor dental pulp cells with the use of fluorescence-activated cell sorting (FACS). 
 60
                                                                                                                                     Chapter 3 
These cells showed self-renewal, osteogenic potential, and generally were more homologous 
than non-sorted cells.21 
As an extension, in the current study, we investigated the multilineage potential of STRO-
1-selected DPCs, again using rat cells. We hypothesized that STRO-1 sorting can have an 
effect on multilineage differentiation of rat dental pulp cells, in other words that STRO-1+ 
cells are more homologous and thus have a higher efficacy and a lesser variability for 
differentiation compared to non-sorted cells. If successful, the rat can be a good model for 
future use, to study tissue regeneration with stem cells derived from e.g. the pulp of extracted 
third molars. 
 
2. MATERIALS & METHODS 
2.1 Cell Culture 
In our previous study, a STRO-1+ cell population was obtained from rat incisor dental pulp 
cells (3rd passage) through FACS (STRO-1 monoclonal antibody, R&D Systems, 
Minneapolis, MN).21 Approximately 0.5% of the total dental pulp cells were sorted as STRO-
1 population. Cells were expanded in minimal essential medium-α (α-MEM; GIBCO- BRL) 
supplemented with 10% fetal calf serum (FCS; GIBCO-BRL) and gentamycin (50 μg/mL; 
Sigma). 
 
2.2 Multilineage Induction In Vitro 
After expansion, STRO-1+ cells were seeded into 24-well plates at a density of 2 x 104 
cells/well in α-MEM supplemented with 10% FCS. 48 hours later, the medium was 
substituted with four inductive media, inducing multiple differentiation pathways (Table 1). 
For the induction of neurogenesis, firstly, pre-neurogenic medium was added to the cells, 
and incubated for 24 hr, followed by neurogenic medium for 5 hr. For the induction of 
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adipogenesis or myogenesis, cells were cultured for 4 weeks in adipogenic or myogenic 
medium. For the induction of chondrogenesis, approximately 250,000 cells were placed in a 
15-ml polypropylene tube (Falcon), and centrifuged to pellet. Then, 0.5 ml of chondrogenic 
medium (PT-3003; Cambrex Bio Science, Verviers,Belgium) was added, freshly 
supplemented with 10 ng/ml TGF-β3.  
The conditioning media were refreshed at 3-day intervals. The first control group was non-
sorted rat dental pulp cells (3rd passage) with the same conditioning media as the sorted cells, 
and the negative control group was the STRO-1+ cell population cultured in non-conditional 
medium. 
Table 1: Lineage-specific differentiation inducing media 
 
Medium Media Serum Supplement 
Pre-neurogenic α-MEM 10% FCS 1mM DMSO 
Neurogenic (NM) α-MEM None 10mM β-Mercaptoethanol (BME), 2% DMSO, 200 μM 
butylated hydroxyanisole (BHA) 
Adipogenic (AM) α-MEM 10% FCS 0.5 mM isobutylmethylxanthine (IBMX), 1 μM 
dexamethasone, 10 μM insulin, 200 μM 
indomethacin, 50 μg/ml gentamycin 
Myogenic (MM) α-MEM 10% FCS, 
5% Horse 
serum 
0.1 μM dexamethasone, 50 μM hydrocortisone,  50 
μg/ml gentamycin 
Chondrogenic (CM) PT-3003 (Cambrex Bio Science, Verviers, Belgium), 10 ng/mL TGF-β3 
Control α-MEM 10% FCS 50 μg/ml gentamycin 
 
2.3 Real-Time Quantitative PCR 
Total RNA of the samples was prepared with the RNeasy kit (Qiagen, Leusden, The 
Netherlands). Purified RNA was measured with the spectrophotometer, and 1μg of RNA was 
used to produce cDNA. The multilineage differentiation capacity of the cells was monitored 
by specific markers (Table 2); i.e. neurofilament and NSE (neurogenesis)；PPARγ2 and 
lipoprotein lipase (LPL) (adipogenesis); myosin and myoD (myogenesis); collagen type II 
and aggrecan (chondrogenesis). GAPDH was used as the house-keeping gene to normalize 
the RNA expression levels. Real-time PCR was performed using the SYBR Green PCR kit 
(Eurogentec, Liege, Belgium) and controlled in a spectrofluorimetric thermal iCycler® 
 62
                                                                                                                                     Chapter 3 
(BioRad, The Netherlands). After the real-time PCR run, a Ct-value was obtained for each 
well. This Ct value showed how many PCR cycles were necessary to obtain a certain level of 
fluorescency. Amplification efficiency of different genes was determined relative to GAPDH 
as an internal control (ΔCt = Ct gene – Ct GAPDH). Interested mRNA in each sample was 
calculated by a comparative ΔΔCt (ΔCt gene –ΔCt control ) value method.22 The fold change in 
gene expression relative to the control was calculated by 2-ΔΔCt. The samples from STRO-1+ 
cells before induction were the control, set as 1.0-fold expression level. Each sample was 
assessed in six-fold. Statistical analysis was performed by unpaired t-testing and P < 0.05 was 
considered significant. Error bars represent means ± standard deviation (SD). 
Table 2:  Rat specific primers for real-time PCR 
  
    Sense primer Antisense primer 
  Neurofilament 5’-TCGCCGCATATAGGAAACTACTG-3’  5’-GAGGGCTGTCGGTGTGTGTAC-3’ 
NSE 5’-TGATGACCTGACGGTGACCA-3’ 5’-CAAACAGTTGCAGGCCTTCTC-3’ 
PPARγ2 5’-CGCTGATGCACTGCCTATGA-3’ 5’-GGGCCAGAATGGCATCTCT-3’ 
LPL 5’-GCAAGGCATACAGGTGCAATT-3’ 5’-GGCAGAGCCCTTTCTCAAATG-3’ 
Myosin 5’-AAATGTTCCCGCTTCCTCAAT-3’ 5’-TCTGAAGCAGCTGTGAGGCA-3’ 
MyoD 5’-GGAGACATCCTCAAGCGATGC-3’ 5’-AGCACCTGGTAAATCGGATTG-3’ 
Collagen type II 5’-GAACAACCAGATCGAGAGCA-3’ 5’-CTCTCCAAACCAGATGTGCT-3’ 
Aggrecan 5’-CTGGAGACAGGACTGAAATC-3’ 5’-CTCCATTCAGACAAGGGCTT-3’ 
GAPDH 5’- GAAGGGCTCATGACCACAGT-3’ 5’- GGATGCAGGGATGATGTTCT-3 
 
2.4 Immunohistochemistry 
The cells induced into the neurogenic, adipogenic, and myogenic differentiation were fixed 
in 4% paraformaldehyde for 15 min. For the chondrogenic culture, samples were fixed in 4% 
formalin, embedded in paraffin, and cross-sectioned (5 μm thick). After blocking with 5% 
BSA/PBS, the samples were incubated with specific primary antibodies for 1 h, and 
subsequently incubated with biotinylated goat or donkey secondary antibodies (1:500 
dilution; Jackson ImmunoResearch, UK) for 45 min. For enzymatic immunohistochemical 
staining, a peroxidase-conjugated avidin-biotin complex (Vectastain ABC staining kit; Vector 
Laboratories, CA) was used. Subsequently, the cells were incubated in DAB solution and 
intensified with 0.5% CuSO4. Haematoxylin was used to counter-stain the nuclei. The 
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following antibodies were used; neuronal nuclei (NeuN, 1:50 dilution ; Chemicon, Temecula, 
CA, USA); neuron specfic enolase (NSE, 1:50 dilution; Santa Cruz, USA); glucose 
transporter-4 (GLUT-4, 1:25 dilution; Santa Cruz, USA); myoblast determination protein 1 
(MyoD, 1:25 dilution; PharMingen, USA); myosin heavy chain (MHC, 1:2 dilution; 
Development Studies Hybridoma Bank, USA); collagen type II (1:50 dilution; Development 
Studies Hybridoma Bank, USA). 
 
2.5 Histochemistry  
  To identify the accumulation of lipid-rich vacuoles in adipogenesis, adipogenic induced cells 
were stained by the Oil red O (Sigma) as follows: cells were fixed with 4% 
paraformaldehyde, treated with 60% isopropanol for 5 min, stained with the working solution 
of Oil red O (0.18%) for 10 min, and then counter-stained with hematoxylin. 
  To determine the presence of sulfated glycosaminoglycans (GAGs) in chondrogenesis, pellet 
samples were stained with Alcin blue as follows: the samples were pre-treated with 3% acetic 
acid for 3 min, stained with 1% Alcian blue (pH 1.0) for 30 min, and then counter-stained 
with 0.1% nuclear fast red. 
 
3. RESULTS 
3.1 Neurogenic Differentiation 
  During neurogenic induction, real-time PCR analysis indicated that the expression levels of 
NSE and neurofilam mRNA in STRO-1+ cells were significantly higher than those in non-
sorted cells with 3.74- and 12.78-fold versus 2.17-and 5.47-fold at hour 2 and 5, compared to 
STRO-1+ cells without induction (Figure 1 A,B). 
STRO-1+ cells underwent a morphological change from fibroblast-like morphology to 
compact neuronal-like cells with thin branches. The cells were fixed and immuno-stained for 
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proteins specific for neural phenotypes, 5 hr past the initial neurococktail incubation. Neural 
differentiation was confirmed by the positive staining with antibodies to NeuN and NSE 
(Figure 2 A-D). In contrast, the STRO-1+ cells that did not receive the inductive medium 
showed negative for the applied staining.  
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 Figure 1: Representative columns of the mRNA levels (2-ΔΔCt) of (A) NSE and (B) neurofilament 
(neurogenesis); (C) PPARγ2 and (D) LPL (adipogenesis); (E) myosin and (F) myoD (myogenesis); (G) 
collagen type II and (H) aggrecan (chondrogenesis). STRO-1+ cells were cultured in inducing media (●) 
or control medium (▼). Non-sorted cells (3rd passage) were also cultured in inducing media (○). The 
STRO-1+ group (●) compared to the non-sorted group (○): * P<0.05, ** P<0.01; STRO-1+ group (●) 
compared to control group(▼): # P<0.05, ## P<0.01. 
 
 
 
 
 
Figure 2: Results of neurogenic differentiation. (A) 
morphological changes of STRO-1+ cells after 
inducement (original magnification 10 X); (B) 
negative control (STRO-1+ cells in control medium); 
(C) immunohistochemical staining for STRO-1+ cells 
after inducement (NeuN); (D) immunohistochemical 
staining for STRO-1+ cells after inducement (NSE). 
(original magnification 20 X) 
 
3.2 Adipogenic Differentiation 
For the adipocyte-specific transcripts, real-time PCR analysis showed that the mRNA 
expression levels of PPARγ2 and LPL were significantly up-regulated with 7.89- and 15.79- 
fold after 4 weeks; as for non-sorted cells, only 5.79- and 6.77-fold up-regulation were 
detected, compared to STRO-1+ cells without induction (Figure1 C, D). 
During 4 weeks of adipogenic induction, the accumulation of lipid-rich vacuoles was 
observed within cells, 2 weeks past initial stimulation. The lipid vacuoles continued to 
develop over time, and were found even more after 4 weeks (Figure 3A). After 4 weeks of 
culture, Oil red O-positive lipid clusters were also demonstrated in STRO-1+ cells (Figure 3 
B). Furthermore, induced cells were found to express GLUT-4, a specific marker of 
adipocytes (Figure 3 C). For the control STRO-1+ cells, the cells showed fibroblast-like 
morphology, and no positive immunostaining was detected (Figure 3 D).  
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Figure 3: Results after adipogenic differentiation. (A) 
morphological changes of STRO-1+ cells after 
inducement; (B) Oil red O staining; (C) 
immunohistochemical staining for GLUT4; (D) 
negative control (STRO-1+ cells in control medium). 
(original magnification 20 X) 
 
3.3 Myogenic Differentiation 
For the myocyte-correlative transcripts, real-time PCR analysis demonstrated that the 
expression levels of myosin and myoD were increased with 16.67- and 12.80- fold in STRO-
1+ cells after 4 weeks, and 7.89- and 7.34-fold in non-sorted cells, compared to STRO-1+ cells 
without induction (Figure 1 E, F). During 4 weeks of myogenic culture, no clear 
morphological changes were found in STRO-1+ cells, and some cells continued to form 
cytoplasmic branches and also showed fibroblast-like morphology. Two weeks after 
induction, cells were found to express MyoD and myosin, specific markers of the myocyte, 
and staining was even more pronounced after 4 weeks (Figure 4 A-D). For the control STRO-
1+ cells, no positive immunostaining was detected. 
 
Figure 4: Immunohistochemical staining after 
myogenic differentiation. (A) myoD  (2 wk); (B) MHC 
(2 wk); (C) myoD (4 wk); (D) MHC (4 wk). (original 
magnification 20X) 
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3.4 Chondrogenic Differentiation 
  Real-time PCR analysis confirmed that the mRNA expression levels of collagen type II and 
aggrecan were obviously up-regulated in STRO-1+ after 4 weeks with 6.90- and 10.28-fold. 
At the same timepoint, there were 4.12- and 8.15-fold expression levels in non-sorted cells, 
respectively compared to control (STRO-1+ cells without induction) (Figure 1 G, H). 
 
Figure 5: Results after chondrogenic differentiation. 
(A) STRO-1+ sample in 4 wk (Alcian blue staining); 
(B) negative control (STRO-1+ cells in control 
medium) in 4wk (Alcian blue staining); (C) STRO-1+ 
sample in 4 wk(immunohistochemical staining for 
collagen type II );  (D) negative control in 4wk 
(immunohistochemical staining for collagen type II ). 
(original magnification 20 X) 
 
 
4. DISCUSSION 
In a previous study, we have successfully isolated STRO-1+ cells from rat incisor dental 
pulp, and confirmed that a STRO-1+ cell population is more homogenous and it capable of 
differentiating into the osteogenic pathway.21 However, no systematic research has been 
performed to evaluate the multilineage potential of this tooth-derived STRO-1+ population, 
and whether the more homogeneous STRO-1+ cell population results in more standardized 
results.  
The present study showed, considering the neurogenic differentiation, a clear 
morphological difference between treated groups and controls. The treated cells showed long 
extensions with multiple filopodia. The expression of NeuN and NSE proteins was also 
detected. Generally, NeuN is known to have expression in most neuronal cell types 
throughout the nervous system, including cerebral cortex, spinal cord, and peripheral nervous 
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system.23 NSE is also localized in the cytoplasm of neurons, and is supposed to serve as a 
growth factor in neurons.24 Under conditional inducement, NeuN and NSE were present in 
STRO-1+ DPCs, analogous to bone marrow stem cells.25 The expression of specific neuronal 
phenotype markers and genotype together with the observed morphological changes in our 
study confirmed the process of neurogenic differentiation. However, these results do not mean 
that these cells possess the full function as neuron. Animal models are required to explore the 
usage of STRO-1+ cells in this field. Simultaneously, the real-time PCR assays can quantify 
and compare the expression levels between different samples. During the whole neurogenesis, 
the non-sorted rat dental pulp cells showed some up-regulation in neurogenic-specific gene 
expression, analogous to hDPSCs.26 However, the gene expression in STRO-1+ cells indicated 
a higher up-regulation compared to the non-sorted cells. These results suggested that the 
STRO-1+ population was more potent in delivering neurogenic cells.  
For the adipogenic differentiation, the protein expression of GLUT-4, and the mRNA 
expression of PPARγ2 and LPL were detected. GLUT-4 and LPL are the widely used 
adipogenic-specific markers.27 PPARγ2 is also a marker for adipogenesis because it is mainly 
expressed in fat tissue and can activate adipocyte differentiation.28 The achievement of true 
adipogenesis however always takes prolonged periods of time.12,19,26 On basis of specific gene 
expression levels, the STRO-1+ group also showed more potential for adipogenesis compared 
to non-sorted cells, during the late period of induction. The trans-differentiation of the 
induced cells was apparent by the accumulation of lipid-rich fields in the cytoplasm in the Oil 
red O staining, which is corroborated by other researchers.5,19,29 
The presence of multiple nuclei is an important characteristic of the terminal mature  
myocyte. However, no classical multinucleated cells could be observed in our study. In 
contrast, both myoD and myosin proved to be positive by immunohistochemistry, and by real-
time PCR after induction. The reason of not finding classical multinucleated cells may be due 
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to the limited culture time in vitro, or due to the absence of a co-culture with a myogenic cell 
line.11 MyoD plays a key role in the early myogenesis by activating muscle-specific genes in 
response to extracellular growth factors,30,31 whereas myosin is regarded as a late marker for 
myogenic differentiation.32 For the control groups, there were no positive markers for 
myocytes, as reported by others.9  
To initiate chondrogenesis, the differentiation was successfully induced when cells were 
cultured as aggregates, as reported earlier in literature.5,33,34 The requirement for this high cell 
density suggests that cell interactions are very important in the chondrogenic system. Also the 
addition of TGF-β1 or TGF-β3 is necessary to induce the chondrogenesis.33-35 The alcian blue 
staining showed that only STRO-1+ cells supplemented with TGF-β3 were able to form a 
structure with an increased sulfated proteoglycan–rich extracellular matrix. This was also 
confirmed by the specific cartilage matrix markers collagen type II (immunohistochemistry 
and real-time PCR) and aggrecan (real-time PCR). However, in our samples some matrix 
degradation or dead cells were found. On the other hand, the differences in specific gene 
expression levels between STRO-1+ cells and non-sorted cells still existed, though less than 
for the other differentiation pathways. This may be due to the excessive number of cells in the 
pellet, which might obstruct the exchange of nutrients; consequently, a three-dimensional 
culture system may be useful for this pellet culture method.  
Based on the results mentioned above, we conclude that the STRO-1+ cell population has 
higher rate of multilineage differentiation than the non-sorted cells. In our second hypothesis, 
we claimed that the STRO-1+ cell population, because of its more homogeneous appearance, 
would result in more standardized results. This was tested by performing the real-time PCR in 
a statistical manner (n = 6, each n consisted of a pool of 3 wells). However, our PCR results 
showed a similar large standard deviation, which indicated comparable variation in results 
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between the 6 samples. Based on that result, we conclude that a higher level of differentiation 
were obtained by cell sorting, but not with more standardized results. 
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1. INTRODUCTION 
Dental pulp stem cells (DPSCs) show mesenchymal stem cell properties, and might be a 
candidate cell type for dental tissue engineering. Previous studies have already demonstrated 
the self-renewal potential of DPSCs and their capacity to differentiate towards odontoblasts in 
vivo,1,2 but the efficacy of DPSCs for practical applications is still under investigation. 
Previous studies have shown a large variability in results of proliferation and differentiation 
phenotypes for DPSCs in vitro as well as in vivo.1-3 Furthermore, our preceding study 
reported that mineralization and bone-like tissue formation in subcutaneously implanted 
DPSC-loaded constructs did not occur.4 This observation questions the potential of DPSCs for 
clinical applications, and illustrates the necessity to optimize stem cell technology. 
Previous in vitro studies have already shown that a more homogeneous strain of DPSCs can 
be derived from pulp biopsies by STRO-1 cell selection.5-7 STRO-1 is described as a marker 
of human mesenchymal stem/precursor cells,8 but selection with this marker also increases 
the ability of odontogenic differentiation of rat DPSCs, as well as development towards other 
differentiation pathways.7,9,10 The addition of growth factors is another strategy that can 
enhance the differentiation of stem cells. For example, recombinant human BMP-2 is known 
to stimulate the odontoblastic differentiation of dental pulp cells.11 The odonto/osteoinductive 
potential of BMP-2 has also been confirmed in clinical studies.12  
Finally, previous studies indicated that in vitro culture time after seeding of the stem cells 
into a porous scaffold is important for the final tissue formation. In similar studies, using 
titanium fiber mesh and osteogenic cells, ectopic bone formation increased when after seeding 
the culturing of cells was continued for a short period of time (1-4 days) before 
implantation.13,14 Evidently stem cells exposed for a longer period to differentiation 
supporting conditions show enhanced differentiation into osteoblasts and, therefore, less 
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proliferation and migratory ability.13 However, all aforementioned knowledge has never been 
considered for dental pulp cell-based tissue engineering.  
Therefore, in this study, we aimed to load STRO-1 selected rat DPSCs onto porous ceramic 
scaffolds (HA/TCP), after treatments with various odonto-inductive media and pre-culture 
times. After implanting subcutaneously into immunocompromised mice, ectopic hard tissue 
formation was evaluated. We hypothesized that (1) STRO-1 selected DPSCs can form 
abundant hard tissue in this in vivo model, and (2) the addition of BMP2 accelerates or 
enhances these results obviously. Further, we hypothesize that (3) the addition of BMP-2 can 
shorten the pre-culture period needed before implantation, which will facilitate final clinical 
application. 
 
2. MATERIALS & METHODS 
2.1 Cell Culture 
Rat DPSCs were selected on the stem cell marker STRO-1 by fluorescence activated cell 
sorting (FACS) as described before.7 Briefly, 10 x 106 cells of the third passage were 
incubated with STRO-1 monoclonal antibody (20 μg/mL, R&D Systems, Minneapolis, MN) 
and phycoerythrin (PE)- conjugated goat anti-mouse IgG antibody (1:50; Sigma). Cells were 
sorted using a FACStar Plus flow cytometer (Beckton Dickinson & Co., Mountain View, CA) 
with positivity defined as a level of fluorescence greater than 99% of the blank (without 1st 
and 2nd antibody reaction) and negative (without 1st antibody reaction) controls. To obtain 
enough cells for the experiments, cells were expanded to the 10th passage in minimal 
essential medium-α (α-MEM; GIBCO-BRL, Breda, The Netherlands) supplemented with 
10% fetal calf serum (FCS; GIBCO-BRL) and gentamycin (50 μg/mL; Sigma). Although not 
quantified,  immunofluorescence microscopy was used to confirm the STRO-1 positive cell 
content after the expansion step. 
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2.2 Three-Dimensional Scaffold 
Sintered HA/TCP Camceram® ceramic discs of a 6mm diameter and 3 mm thickness with 
a HA/TCP ratio of 60/40 were kindly provided by CAM Implants (Leiden, the Netherlands). 
The volumetric porosity of the discs was 90%. The discs were sterilized by autoclaving. 
 
2.3 In Vitro Analysis 
2.3.1 Cell Seeding 
All scaffolds were pre-wetted in α-MEM medium with 10% FCS and 50 µg/ml gentamycin 
overnight. After that, STRO-1 selected DPSCs were seeded onto the scaffolds by submerging 
the scaffolds in a suspension of 5.0x106 cells/ml while gently rotating at 6 rpm for 3 hrs. For 
every 6 scaffolds, 1 ml cell suspension was used. Subsequently, the scaffolds were put in 24-
well plates with 1 ml of medium, which was replaced at 3-day intervals. Three different 
media were used: 
(1)  “BMP-plus”, i.e. α-MEM supplemented with 10% FCS, 10 mM sodium β-
glycerophosphate, 10-8 M dexamethasone, L-ascorbic acid (50μg/mL),  gentamycin 
(50μg/mL), and 100ng/mL of rhBMP-2 (R&D Systems).15 
(2) “odontogenic” medium, i.e. α-MEM supplemented with 10% FCS, 10 mM sodium β-
glycerophosphate, 10-8 M dexamethasone, L-ascorbic acid (50μg/mL), and 
gentamycin (50μg/mL) similar to our previous study.4   
(3) “control” non-odontogenic medium, i.e. α-MEM supplemented with 10% FCS and 
50μg/mL gentamycin only. 
  
2.3.2 Cell Numbers and Alkaline Phosphatase Activity 
On day 1, 4, and 8 post-seeding, the cell number was determined by total DNA content (n = 
3), using the PicoGreen assay as described previously.16 The same samples were also used to 
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measure alkaline phosphatase (ALP) activity. Twenty μL of 0.5 AMP buffer (Sigma) was 
added to 80 μL of the samples or standards. Next, 100 μL of substrate solution was added and 
the mixtures were incubated at 37 ◦C for 1 h. ALP activity was measured at 405nm, using an 
ELISA microplate reader (Bio-Tek Instruments Inc., USA).16 
 
2.3.3 Scanning Electron Microscopy (SEM) 
On day 1, 4, and 8 post- seeding, cell/scaffold complexes were rinsed with filtered PBS, 
and fixed in 2% glutaraldehyde for 5 min, dehydrated in graded series of ethanol, and dried in 
tetramethylsilane (Merck, Germany). Gold was sputtered on the samples just before SEM 
analysis. The specimens were examined with a JEOL 6310 SEM. 
 
2.4 In Vivo Analysis 
For the in vivo analysis, cells were seeded as described above. Besides the three media, 
also three different post-seeding incubation times were studied, i.e. 1, 4, or 8 days, resulting in 
9 study groups. In total, 8 samples of each group were used for in vivo analysis. Eighteen 10-
week-old BALB/c immunocompromised nude mice were used after approval from the 
Radboud University Nijmegen Animal Ethics Committee (RU-DEC 2006-134). National 
guidelines for the care and use of laboratory animals were obeyed. Surgery was performed 
under general anaesthesia (isoflurane 1.5-3%). The backs of the mice were washed and 
disinfected with povidone-iodine. On each flank, parallel to the spinal column, two small 
incisions of about 10 mm were made through the skin. Using blunt dissection, subcutaneous 
pockets were created. To avoid cross over effects, each mouse received always 4 implants of 
the same culture medium and pre-culture time group. After implant placement the wounds 
were closed using staples.  
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2.4.1 Light Microscopical Assessment 
After 12 weeks of implantation, the samples were retrieved. Four samples of each group 
were fixed in formalin, dehydrated in a series of ethanol, and embedded in 
methylmethacrylate (MMA). After polymerization of the MMA, at least three thin transversal 
sections (10µm) of each tissue block were made using a modified sawing microtome 
technique.17 The sections were stained with methylene blue/basic fuchsin and analyzed using 
light microscopy.  
Furthermore, image analysis was performed to evaluate the quantity of hard tissue 
formation in different specimens. Three tissue sections per implant were digitized at low 
magnification (2.5 x), allowing coverage of the entire implant. Using the Leica® Qwin Pro 
image analysis system (Leica, Wetzlar, Germany), the areas of the ceramic scaffold and the 
novel bone-like tissue were detected. The outline of the implant area was designed as the 
region of interest (ROI). Then, with the use of the image analysis software, the surface area of 
bone-like tissue (BSA) and the percentage of bone-like area (BSA/ROI) were 
calculated.13,18,19 
 
2.4.2 Real-time Quantitative PCR 
The remaining 4 samples of each group were used for real-time PCR analysis. Fibrous 
tissue capsules and other surrounding tissues were removed immediately after the retrieval of 
the samples. The calcium phosphate scaffolds together with the interstitial tissues were cut 
into small pieces and transferred to liquid nitrogen. Before use, samples were defrosted and 
total RNA of each sample was prepared with a Qiagen RNEasy kit (RNeasy kit, QIAGEN, 
Venlo, The Netherlands). Then, 1 μg of total RNA was used to perform the reverse 
transcriptase (RT)-reaction. The obtained cDNA was used as a template in PCR. The 
odontogenic differentiation of cells was monitored by analyzing the specific markers 
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osteocalcin (OC), bone sialoprotein (BSP), dentin sialophosphoprotein (DSPP), and dentin 
matrix protein 1 (DMP-1). GAPDH was used as house-keeping gene to normalize RNA 
expression (Table 1). 
Real-time PCR was performed using the SYBR Green PCR kit (Eurogentec, Liege, 
Belgium) and controlled in a spectrofluorimetric thermal iCycler® (BioRad, The 
Netherlands). After the real-time PCR run, the Ct-value showed how many PCR cycles were 
necessary to obtain a certain level of fluorescence. Amplification efficiency of different genes 
was determined relative to GAPDH as an internal control (ΔCt = Ct gene – Ct GAPDH). The 
mRNA in each sample was calculated by the comparative ΔΔCt (ΔCt gene – ΔCt control ) 
value method. Each measurement was assessed in triplicate. 
Table 1:  Rat specific primers for real-time PCR 
 
 Sense primer Antisense primer 
OC 5’-GGCTTCCAGGACGCCTACA-3 5’-CATGCCCTAAACGGTGGTG-3’ 
DSPP 5’-GTGAGGACAAGGACGAATCTGA-3’ 5’-CACTACTGTCACTGCTGTCACT-3’ 
DMP-1 5’-GCGCGGATAAGGATGA-3’ 5’-GTCCCCGTGGCTACTC-3’ 
BSP 5’-ACTTCCCTTCGCAAGCTTAGG-3’ 5’-AAACTTCCCGCGTATGTTGG-3’ 
GAPDH 5’- GAAGGGCTCATGACCACAGT-3’ 5’- GGATGCAGGGATGATG TTCT-3 
 
2.5 Statistical Analysis 
Statistical significance was evaluated using one way-ANOVA with post-hoc Tukey testing, 
and P < 0.05 was considered significant. Error bars represent mean ± standard deviation (SD). 
 
3. RESULTS 
3.1 In Vitro Analysis 
3.1.1 Cell Proliferation and ALP Activity 
The total DNA measurement revealed that there were significant differences between the 
three medium groups (BMP-plus, odontogenic, and control) (Figure 1A). Supplementation of 
BMP-plus medium affected proliferation, as the cell number decreased from day 1 to day 8, 
and consistently showed a significantly lower level compared to the other two groups. On the 
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other hand, the absence of dexamethasone and BMP in the control group resulted in increased 
proliferation. The ALP activity of cells is depicted in Figure 1B. The ALP activity gradually 
increased from day 1 to 8 in all three groups. Still the BMP-plus group always showed 
significantly higher levels compared to the other two groups, with exception of BMP-plus vs. 
odontogenic at day 8. 
  
Figure 1: (A) The proliferation characteristics; (B) ALP activity. The bars represent the means ± SD 
(n=3). BMP-plus medium compared to odontogenic medium: * P<0.05, * * P<0.01; BMP-plus medium 
compared to control medium: # P<0.05, ## P<0.01; odontogenic medium compared to control medium: 
‡<0.05, ‡‡P<0.01. 
 
3.1.2 SEM Morphology 
One day post-seeding, SEM examination showed that cells had adhered well and  spread 
fully on the surfaces of the HA/TCP ceramic scaffolds (Figure 2A-C). There were no obvious 
morphological differences among three medium groups. With increasing culture time, a 
noticeable amount of mineralized globular accretions were observed on cell/scaffold 
complexes in BMP-plus medium on day 4 (Figure 2D). For odontogenic culture group, only 
sparse mineralized deposits were found (Figure 2E). The control group only showed cells 
growing on the scaffolds (Figure 2F). On day 8, more numerous and larger mineralized 
nodules covered the surfaces of cell/scaffold complexes in BMP-plus and odontogenic 
medium groups (Figure 2G,H), but the latter also showed the presence of cells on top of the 
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mineralized matrix. For the control group, an intact cell-layer was present without obvious 
mineralized deposits (Figure 2I). 
 
Figure 2: Scanning electron micrographs of three groups with different pre-culture periods. (A) BMP-2 
plus group on day 1; (B) odontogenic group on day 1; (C) control group on day 1; (D) BMP-2 plus group 
on day 4; (E) odontogenic group on day 4; (F) control group on day 4; (G) BMP-2 plus group on day 8; 
(H) odontogenic group on day 8; (I) control group on day 8. Arrows indicate some of the calcified nodules. 
 
3.2 In Vivo Analysis 
All mice appeared to be in good health throughout the test period except for one, which 
suffered from a viral contamination not related to the experiment, and was excluded from 
further evaluation. This mouse contained four samples of constructs treated with odontogenic 
medium and 4 days of in vitro pre-culture time. After sacrifice, all other implants were 
retrieved with the surrounding soft tissues intact.   
 
3.2.1 Light Microscopic Evaluation 
Histological observation indicated that all HA/TCP ceramic implants after the 12 week 
implantation period were encapsulated with a thin fibrous tissue capsule, closely following 
 85
Hard Tissue Formation of STRO-1 Selected Rat Dental Pulp Stem Cells In Vivo  
the outer perimeter of the scaffold. Inflammatory cells were only sporadically present. Tissue 
ingrowth was found in all the implants and macro-pores of scaffolds were filled with fibrous 
tissue.  
For the implants with one-day pre-culture, obvious hard tissue formation had occurred in 
both the BMP-plus and odontogenic medium groups (Figure 3A,B). The newly formed hard 
tissue was stained deep red by the basic fuchsin and was present mainly along the surface of 
the porous ceramic material. Furthermore, at higher magnification (Figure 4A,B), distinct 
concentric lamellae were observed with entrapped osteocyte-like cells and osteoblast-like 
cells lying orderly arranged at the surface. Bone-marrow-like hematopoietic tissue was also 
seen together with the newly formed hard tissue. The constructs pre-cultured in control 
medium, showed no evident hard tissue formation (Figure 3C). At higher magnification, an 
orderly arranged thick collagen-like extracellular matrix (ECM) with multiple-layers of cells 
was seen along the pore surface (Figure 4C).  
Also the 4 days of pre-culture samples in odontogenic, and especially in BMP-plus 
medium, showed upon visual inspection enhanced hard tissue formation compared to control 
medium (Figure 3D,E,F). 
After 8 days of pre-culture, hard tissue was formed only sporadically in samples that had 
been grown in odontogenic or BMP-plus medium (Figure 3G,H). At higher magnification, 
these specimens revealed the presence of a granular-like mineral deposit accumulated on the 
surface of the scaffold (Figure 4D). Another difference with the one- or four-day pre-culture 
groups was that this deposit lacked a typical bone-like structure, and osteocyte-like and 
osteoblast-like cells were absent. On the other hand, the implants treated with control medium 
showed a small amount of hard tissue formation (Figure 3I). 
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Figure 3: General overview of the implants of 12 weeks (methylene blue basic/fuchsin staining) with 
different pre-culture periods. (A) BMP-2 plus group with 1 day pre-culture; (B) odontogenic group with 1 
day pre-culture; (C) control group with 1 day pre-culture; (D) BMP-2 plus group with 4 days pre-culture; 
(E) odontogenic group with 4 days pre-culture; (F) control group with 4 days pre-culture; (G) BMP-2 plus 
group with 8 days pre-culture; (H) odontogenic group with 8 days pre-culture; (I) control group with 8 
days pre-culture. Scale bar is 400 µm. 
 
 
Figure 4: Histology and morphology of implants of 12 weeks at a high magnification (methylene blue 
basic/fuchsin staining). (A) BMP-2 plus group with 4-day pre-culture (original magnification 20X), bar 
size is 50 µm; (B) BMP-2 plus group with 4-day pre-culture, the section showed the orderly array of 
osteoblast-like cells on the surface of bone-like matrix (arrow) (original magnification 40X), bar size is 25 
µm; (C) control group with 4-day pre-culture, the section showed multiple-layers of cells orderly arranged 
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along the pore surface (arrow) (original magnification 20X), bar size is 50 µm; (D) BMP-2 plus group with 
8-day pre-culture, the section showed the presence of a mineralized matrix however lacking osteocyte-like 
cells (arrow) (original magnification 20X), bar size is 50 µm. 
 
3.2.2 Histomorphometry 
In Figure 5 the percentages of bone formation in the various scaffold groups are depicted. 
Comparison of the different media groups of the 1-day pre-culture samples revealed that 
significantly more bone-like tissue formation had occurred in the BMP- plus group compared 
to the odontogenic medium, as well as to the control medium group. The odontogenic group 
showed also significantly more bone formation than the control group. Similar significant 
differences were found for the 4 day pre culture specimens. On the other hand, in the 8 days 
of pre-culture time group, a very different response was seen. Here, the BMP-plus and 
odontogenic group both revealed significantly less bone formation than the control medium 
group. Mutual comparison of the different pre-culture time points showed that bone formation 
in the BMP-plus and odontogenic groups peaked with four days of pre culture and was 
significantly higher compared to 1- and 8-days. In contrast, for the control group, the values at 
8 days of pre-culture were significantly higher than for 1 or 4 days of pre-culture, but still 
significantly lower compared with BMP-plus and odontogenic medium groups at 4 days of 
pre-culture.  
 
Figure 5: Histomorphometrical results showing the percentage 
of bone-like tissue formed in the implants of the different groups. 
The bars represent the mean ± SD (n = 4). BMP-plus medium 
compared to odontogenic medium: * P<0.05; BMP-plus 
medium compared to control medium: ## P<0.01; odontogenic 
medium compared to control medium: ∆ p<0.05, ∆∆ P<0.01; 
BMP-plus medium (4 days) compared to BMP-plus medium (1 
or 8 days): ‡‡ P<0.01.
3.2.3 Real-Time PCR 
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Expression levels of mRNA for OC, Bsp, Dspp, and Dmp1 were compared among the three 
groups. mRNA expression levels of samples of the control group at 1-day pre-culture were set 
as baseline control (relative expression value, 100%). It was striking that the expression of 
these four genes showed similar profiles to each other (Figure 6). The most noticeable 
differences were that BMP-plus treated constructs demonstrated significant up-regulation of 
expression of all 4 measured genes in the 4 days pre-culture group compared to both 1 and 8 
days of pre-culture. The odontogenic group also revealed the same expression profiles for 
these genes, although generally significantly lower values were found compared to BMP-plus. 
In the control medium-treated constructs, low gene expression levels were seen in the samples 
with 1-day or 4-day pre-culture, however these significantly had increased at 8 days of 
preculture time.  
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Figure 6: Curves of the mRNA levels of OC (A); BSP (B); DSPP (C); DMP-1 (D); quantified for the in 
vivo specimens. The bars represent the mean ± SD (n = 3). (E) The statistics of (A)-(D). * P<0.05; ** 
P<0.01 – P>0.05. B=BMP-plus medium; O=Osteogenic medium; C=Control medium; 1=one day of pre 
culture time; 4=four days of pre culture time; 8=eight days of pre culture time. B-O= BMP plus medium 
compared to Osteogenic medium, and so on. 
 
4. DISCUSSION 
The use of dental pulp stem cells is an essential component in dental tissue engineering. 
The aim of the current study was to evaluate the efficacy of STRO-1-selected DPSCs for the 
regeneration of (dentin-like) hard tissue, especially regarding the effect of BMP-2 treatment 
and pre-culture time. 
Here, a porous calcium phosphate ceramic carrier was selected as scaffold material. Such 
ceramic also is used in other studies for hard tissue regeneration, because of its bone-
compatible character and the ability to support the differentiation of osteogenic cells.20 
However, in our previous study using similar material but non-homogeneously selected 
DPSCs, only poor amounts of hard tissue were formed under the same condition as our 1 
day/osteogenic group.4  Our current study demonstrated abundant hard tissue formation in the 
STRO-1 positive DPSCs/HA/TCP implants. The STRO-1 selection evidently resulted an 
enriched subpopulation with improved mesenchymal stem cell-like properties of more 
committed progenitors.7-9 These more homogeneous DPSCs loaded and implanted 
subcutaneously then resulted in enhanced hard tissue formation in vivo. This method therefore 
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seems advantageous for therapeutical applications, compared to the use of non-selected 
primary cells as described before.  
Further, to enhance the hard tissue regeneration potential of the cell/scaffold construct 
several additional cell culture parameters can be modified during and after seeding, e.g. by 
optimizing the number of loaded cells.4,14,19,21 A high cell density was used in the current 
study. High cellularity is known to enhance cell-to-cell contact and communication between 
cells, and has a positive effect on cell attachment and differentiation.14,22 Moreover, relatively 
high numbers of cells loaded onto a scaffold previously were shown to benefit ectopic hard 
tissue formation.3 To achieve such high cell numbers, repeated passaging of cells was 
necessary. Apparently, such an extended culture protocol did not negatively influence the 
differentiation properties of the STRO-1-selected cells as was observed before for non-
selected cells.4,7,9  
Enhancement in the odontogenic potential of our DPSCs/scaffold constructs can also be 
achieved by pre-culturing the complexes in the presence of stimulatory media supplements, 
which allows the differentiation of cells towards the odontoblast phenotype, and the secretion 
of dentin-like extracellular matrix (ECM).13,14,19 During this pre-culture period, such ECM has 
been reported to encourage the odontoblast differentiation in vitro.23,24 However, there is an 
inverse relationship between cell proliferation and differentiation. Therefore it has to be 
emphasized that during this preculture period, the occurrence of a mismatch in too much 
differentiation and not sufficient proliferation has to be prevented. Previous studies have 
indicated already that bone marrow cells (BMCs) only require short culture period (1 or 4 
days) to show bone-like tissue formation after implantation in an orthotopic site. Furthermore, 
BMCs-loaded in titanium fiber mesh, with prolonged culturing of 8-16 days before 
implantation, resulted in a very limited amount of bone-like tissue formation after 
implantation.13,14,19,25 Our current study also showed that the hard tissue formation increased 
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with pre-culture times from 1 to 4 days, but significantly decreased when prolonging the pre-
implantation culture time to 8 days. ALP is regarded as an early marker of osteogenic 
differentiation, which indicates the ability of hard tissue formation.16,27 We suppose that 
DPSCs, when implanted need to be at a very immature stage where the ALP activity is still at 
a basal level and cells still have a strong proliferation potential.19,26 With longer incubation 
time (i.e. 8 days), the differentiation of DPSCs towards a mature stage eventually occurred, 
with deposition of considerable amounts of mineralized ECM in vitro.19 Evidently, matured 
cells lose their proliferative potential, which explains the poor hard tissue formation in vivo. 
In conclusion, the in vitro cell phenotype or developmental stage definitely affects the in vivo 
performance. Four days of odontogenic stimulation drives DPSCs to the preferable stage, with 
a balance between proliferation and differentiation, and is most suitable for therapeutic 
applications in vivo.  
As part of the current study, BMP-2 was supplemented in odontogenic media (‘BMP-
plus’). The addition of BMP-2 can induce odontoblastic differentiation of DPSCs in cell 
culture and induces the formation of reparative dentin in vivo.11,28 In the current study it was 
shown that such BMP-plus medium enhanced the differentiation level of DPSCs in vitro and 
significantly increased the amount of hard tissue formation in vivo. Moreover, we 
hypothesized that the addition of BMP-2 can reduce the pre-culture period compared to 
control medium, which was proven true by our results. One remark that must be made 
however is that no full randomization was applied. Since growth factor-loaded samples might 
influence neighboring samples placed in the subcutaneous area of a small animal like the 
mouse, we here decided to only use one pre-treatment type per mouse to avoid cross-over 
effects. Multiple mice were used for each group, without noticeable differences in reaction 
from mouse to another. Still, some additional influence of the host animal cannot totally be 
excluded.  
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The mRNA expression of OC, BSP, DSPP, and DMP-1 were chosen as markers for the 
odontogenic phenotype. OC and BSP are usually regarded late markers for osteoblast 
differentiation and play an important role in hard tissue regeneration.29 DSPP is the major 
dentinal non-collagenous protein and plays a crucial role during dentin mineralization.30 
DMP-1 is another specific protein for dentin and is mostly known as the candidate gene for 
the disorder dentinogenesis imperfecta.31 The expression of these specific markers was most 
effectively enhanced by the addition of BMP-2 to the medium, compared to the 
dexamethasone containing odontogenic medium alone. The in vivo gene expression 
confirmed the dentin-like hard tissue formation in vivo. Furthermore, the expression of DSPP 
suggested a distinct developmental functionality in vivo,32 although the implants did not show 
the typical dentin-like appearance. Improved scaffold designs in composition as well as 
morphology can facilitate the formation of more natural tissue constructs, and have to be 
investigated next. 
Interestingly, the DPSC/scaffold constructs pre-cultured in our control medium showed a 
gradual increase of hard tissue formation, but still at a low amount compared to the BMP-plus 
and dexamethasone-treated groups. This may be partially due to the HA/TCP ceramic. A 
previous study demonstrated that this scaffold material did not only support abundant 
ingrowth of tissue and vasculature, but also induced calcification [4]. Moreover, cells growing 
in multilayers also showed evidence for odontogenic differentiation, after a long in vitro 
culture time.33  
Still the overall result should be regarded critically. Although he supplements used in this 
and other dental tissue engineering studies are often described as "odontogenic" neither 
dexamethasone nor BMP-2 are, strictly speaking,  odontogenic. As said, such formulations 
have also been widely used as an osteogenic supplement to promote osteoblast differentiation 
from bone marrow mesenchymal stem cells. So far, we have not been able to truly define 
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odontogenic conditions. The results of the study reflect this problem, as the observed hard 
tissue is very bone-like, with distinct concentric lamellae, osteocyte-like cells, and bone 
marrow-like hematopoetic tissue, even though the dentin-specific proteins Dspp and Dmp-1 
were upregulated as observed by the real-time PCR.  Still, to actually progress to potential 
therapeutic applications towards dentinal restoration either the development of a better 
suitable scaffold, or direct implantation into dentinal tissue as we performed before seems 
essential.34 
 
5. CONCLUSIONS 
Based on our results, we conclude that STRO-1-selected rat dental pulp stem cells can form 
abundant hard dentin-like tissue after subcutaneous implantation on a ceramic carrier, and 
thus exhibit great potential for therapeutic application. Furthermore, the culture period 
between cell seeding and implantation needs to be optimized to maximize the efficacy of 
tissue regeneration. After 4 days of dexamethasone and/or BMP-2 induced stimulation, 
DPSCs formed the highest amounts of hard tissue in vivo. The addition of BMP2 further 
accelerated the odontoblastic differentiation of DPSCs and overall enhanced the amount of 
hard tissue formation. 
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1. INTRODUCTION 
Tissue engineering requires three key elements: morphogenetic signals including growth 
and differentiation factors, responding stem cells, and a biocompatible scaffold.1 Stem cells 
have been isolated from many tissues, including bone marrow, neural tissue, skin, fat, and 
muscle. Currently, mesenchymal stem cells have also been found in dental pulp tissue.2-4 Such 
dental pulp-derived adult stem cells (DPSCs) exhibited multilineage potential, and were able 
to differentiate towards odontoblast-like cells, adipocytes, myocytes, and neural cells.2-6 
Interestingly, these cells were relatively easy to expand in vitro, and could be passaged for 
more than 25 times.3 However, as a new stem cell source for tissue engineering, the in vivo 
transplantation of such cells in porous calcium phosphate, collagen, or titanium fibre mesh did 
not show adequate hard-tissue formation.5,7 These results suggest a hierarchy of progenitors in 
adult dental pulp, including a minor population of self-renewing, highly proliferative, 
multipotent stem cells, among a larger compartment of probably more committed 
progenitors.5  
For successful tissue engineering strategies, stem cell technology needs to be optimized. 
Previous studies have already shown that dental pulp cells could be derived from human or 
even rat biopsies by STRO-1 cell selection.4,6,8,9 STRO-1 is described as a marker of 
mesenchymal stem/precursor cells,9,10 and selection with this marker increases the ability of 
osteo/odontogenic differentiation, as well as development towards other differentiation 
pathways.6,9-13  
  Another strategy to enhance the efficacy of stem cells could be the addition of growth 
factors. Recombinant human BMP-2 can stimulate differentiation of dental pulp cells into 
odontoblasts.14 The osteoinductive potential of recombinant human BMP-2 has also been 
confirmed in clinical studies.15 However, there are some limitations for local delivery of 
BMP, including short half-life, large dose requirement, high cost, the need of repeated 
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applications, and poor distribution.16 Possibly, transfer of the Bmp2 gene into DPSCs could 
solve this problem. Recently, several studies showed that adenoviral-mediated bone 
morphogenetic protein-2 (AdBMP-2) transfected cells in bone implants were capable of 
stable expression of BMP-2 and revealed exciting results in ectopic osteoinduction animal 
models.17 Furthermore, adenoviruses are well-known for efficient delivery of therapeutic 
genes, and have already been applied for clinically relevant gene therapy.18 
In this study, the differentiation characteristics of transfected STRO-1 selected rat DPSCs 
with adenoviral-mediated human Bmp2 gene were evaluated. We hypothesized that Bmp2 
transfected cells have an increased odontogenic differentiation potential, compared to non-
transfected cells, even when cultured in medium without dexamethasone or other stimuli. 
 
2. MATERIALS & METHODS 
2.1 Cell Culture 
STRO-1 selected rat DPSCs (10th passage), as obtained by FACS,9 were expanded in 
minimal essential medium-α (α-MEM; GIBCO-BRL, Breda, The Netherlands) supplemented 
with 10% fetal calf serum (FCS; GIBCO-BRL) and gentamycin (50 μg/mL; Sigma). The 
multilineage potential of this cell population was confirmed in a previous study.19 
 
2.2 Adenovirus Gene Transfer 
A replication-deficient adenoviral vector carrying the human Bmp2 gene, AdBMP-2, was 
used in the current study. Firstly, to acquire effective gene transfer, an optimum multiplicity 
of infection (MOI) was evaluated. Cells were seeded in a 24-wells plate with a density of 2 x 
104 cells/well. AdBMP-2 was added to the cells with different MOI (0, 5, 10 and 100) (n = 4). 
48 hours after transfection, the presence of BMP-2 in the culture supernatants was tested 
using a modified BMP-selective reporter bioassay (BRE-luc) inducing luciferase expression. 
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Luciferase activity was quantified using the Bright-Glo™ Luciferase Assay System 
(Promega, Madison, WI, USA). For the standard curve, serial dilutions of rhBMP-2 (R&D 
Systems, Abingdon, United Kingdom) were used. The lower detection limit of this assay was 
1.6 ng/ml BMP-2.  
Secondly, after achieving the optimum MOI, the cells were plated in the same density in 
24-well plates. 24 hours after seeding, cells were infected with AdBMP-2 (dilution in α-
MEM) at the optimum MOI. The transfected and non-transfected cells were cultured for 24 
days in α-MEM supplemented 10% FCS and 50 μg/mL gentamycin. Culture medium was 
changed at 3-day intervals. 
 
2.3 Cell Proliferation and ALP Activity  
1, 4, 8, 12, 16 and 24 days after gene transfer, the proliferation rates of the cells, as 
measured by total DNA content (n=6 for each time point), were assessed with a PicoGreen 
dsDNA quantification kit (Molecular Probes, Leiden, The Netherlands).4 1 mL of Milli-Q 
water (Millipore, Billerica, MA) was added to each well to lyse the cells. 100 μL of 
PicoGreen working solution was added to 100 μL supernatants of samples. After incubation, 
the fluorescence of each sample was measured with a fluorescence microplate reader (Bio-
Tek Instruments Inc., USA), with excitation filter 365 nm and emission filter 450 nm, and the 
DNA amounts were calculated from a standard curve.  
The same supernatants as used for the PicoGreen assay were also used to measure cellular 
ALP activity (Sigma). 20 μL of 0.5 M 2-amino-2-methyl-1-propanol (AMP) buffer was added 
to 80 μL of the samples or standards. Next, 100 μL of substrate solution (p-nitrophenyl 
phosphate) was added and the mixtures were incubated at 37℃ for 1 h. ALP activity was 
measured at 405nm using an ELISA microplate reader (Bio-Tek Instruments Inc, USA).  
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2.4 Calcium Content 
4, 8, 12, 16 and 24 days after gene transfer, the rate of calcified extracellular matrix 
deposition was assessed by measuring the calcium content of the samples (n = 6), using a 
ortho-cresolphthalein complexone (OCPC, Sigma) method. 1 mL of 1 M acetic acid was 
added to each well overnight. Working solution was prepared: 5 mL of OCPC solution was 
added to 5 mL of 14.8 M ethanolamine-boric acid buffer (pH 11), 2 mL of 8-
hydroxyquinoline, and 88 mL of Milli-Q water. 10 μL of sample or standard was added to 300 
μL working solution. Serial dilutions of CaCl2 were used to generate a standard curve. The 
plate was incubated at room temperature for 10 minutes then read at 575 nm (Bio-Tek 
Instruments Inc, USA). 
 
2.5 Scanning Electron Microscopy (SEM) 
Cells were cultured on coverslips (Thermanox®) (n = 2), and fixed in 2% glutaraldehyde (5 
min) on 1, 8, and 16 days after gene transfer. They were then dehydrated in graded series of 
ethanol, and dried in tetramethylsilane (Merck, Germany). Gold was sputtered on the samples 
just before SEM analysis. The specimens were examined with a JEOL 6310 Scanning 
Electron Microscope. 
 
2.6 Real-time Quantitative PCR 
At day 1, 4, 8, and 16 after gene transfer, total RNA of every sample was isolated with the 
RNEasy kit (Qiagen, Venlo, The Netherlands). Quantity and quality of the RNA was 
measured with the spectrophotometer (SmartSpecs® Plus, Biorad Laboratories, Veenendaal, 
The Netherlands). 1μg RNA was used to make cDNA with the RT-PCR method (Invitrogen, 
Breda, The Netherlands). To perform quantitative PCR, a SYBR® Green PCR kit was used 
(Eurogentec, Liege, Belgium), and reactions were controlled in a spectrofluorimetric thermal 
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iCycler® (Biorad, Richmond, CA, USA). The odontogenic differentiation was monitored by 
six markers: alkaline phosphatase (ALP), osteocalcin (OC), collagen type I (Col I), bone 
sialoprotein (BSP), dentin sialophosphoprotein (DSPP), and dentin matrix protein-1 (DMP-1). 
GAPDH was used as housekeeping gene to normalize RNA expression (Table 1). 
DNA was PCR-amplified under the following conditions: 2 minutes at 50 ºC and 10 
minutes at 95 ºC, followed by 40 cycles of 15 seconds at 95 ºC and 1 minute at 60 ºC, with 
data collection in the last 30 seconds. After the real-time PCR run, a Ct-value showed how 
many PCR cycles were necessary to obtain a certain level of fluorescence. Amplification 
efficiency of different genes was determined relative to GAPDH as an internal control (ΔCt = 
Ctgene – CtGAPDH). mRNA in each sample was calculated by a comparative ΔΔCt (ΔCtgene –
ΔCtcontrol) value method. The fold change in gene expression relative to the control was 
calculated by 2-ΔΔCT.20 Each sample was assessed in triplicate. 
Table 1: Rat-specific primer sequences used for real-time PCR 
 Sense primer Antisense primer 
Alp 5’-GCTTCACGGCATCCATGAG- 3’  5’-GAGGCATACGCCATGACGT-3 
OC 5’-GGCTTCCAGGACGCCTACA-3 5’-CATGCCCTAAACGGTGGTG-3’ 
Col I 5’-TGGAATCTTGGATGGTTTGGA-3’ 5’-GCTGTAAACGTGGAAGCAAGG-3’ 
Dspp 5’-CGGTCCCTCAGTTAGTC-3’ 5’-TACGTCCTCGCGTTCT-3’ 
Dmp1 5’- CGTTCCTCTGGGGGCTGTCC -3’ 5’- CCGGGATCATCGCTCTGCATC -3’ 
Bsp 5’-ACTTCCCTTCGCAAGCTTAGG-3’ 5’-AAACTTCCCGCGTATGTTGG-3’ 
Gapdh 5’- GAAGGGCTCATGACCACAGT-3’ 5’- GGATGCAGGGATGATGTTCT-3 
 
2.7 Oligo microarray 
RNA samples of day 0, and 8 were analyzed with the Oligo GEArray Rat osteogenesis 
microarray (Cat. No. ORN-026; SuperArray, Bioscience Corporation, Frederick, USA). 
According to the instructions by the manufacturer, an annealing mix was made with 1 μg 
RNA to synthesize cDNA. The Amplification Master mix was then added to the cDNA 
synthesis mix and incubated overnight at 37°C to produce cRNA, respectively. After 
prehybridizing the array membrane with the GEAhyb Hybridisation solution, 10 µg of cRNA 
in 750 µl Hybridisation buffer was added in the membrane to allow hybridisation overnight at 
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60°C. Afterward, the membrane was blocked for 40 minutes by GEAblocking solution. 
Subsequently, 2 ml AP-streptavidin (1:7500) was added to the membrane and incubated for 
10 minutes. Finally, the membrane was incubated with 1 ml of CDP-star chemiluminescence 
substrate at room temperature for 5 minutes. Then, the membrane was exposed to a X-ray 
film for detection. The images were analyzed by the GEArray Expression Analysis Suite 
(GEASuite). 
 
2.8 Statistical Analysis 
Statistical significance in this study was evaluated using paired-t testing and P < 0.05 was 
considered significant. Error bars represent means ± standard deviation (SD). 
 
3. RESULTS 
3.1 Gene Transfer and Cell Proliferation 
The test for MOI showed that cells could be transfected with BMP-2 adenovirus. After 48 
hours, the transfected cells secreted 4.3, 5.0, 34.5, and 101.9 ng/ml hBMP-2 at MOI 0, 10, 50, 
and 100 respectively. Therefore, in the main study, cells were infected with AdBMP-2 at a 
MOI of 100. After gene transfer, both populations showed exponential growth for 24 days. 
Cells grew more rapidly in the non-transfected group than in the transfected group (P<0.05) 
(Figure 1 A).  
 
3.2 ALP Activity and Calcium Content 
The transfected cells showed increasing ALP activity until day 16. At day 24, the ALP 
activity decreased. The transfected cells showed significantly higher levels of ALP activity 
compared to non-transfected cells (P<0.01) (Figure 1 B). Finally, significantly higher levels 
of Ca were observed at day 12,16 and 24 for the transfected cells (P<0.01) (Figure 1 C). 
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Figure 1: Growth characteristics of transfected 
and non-transfected cells cultured in non-
osteogenic medium. (A) The Proliferation 
characteristics (B) ALP activity, and (C) Calcium 
content. The bars represent the means ± SD 
(n=6). * P<0.05, * * P<0.01. 
 
 
3.3 SEM Analysis 
  One day after transfection, SEM analyses showed that all cells had spread well on the 
surface of the coverslips. Mostly all cells had multiple filopodia, and nuclei and nucleoli 
could be observed clearly. There were no differences between the two groups (Figure 2 A, B). 
Although no external source of phosphate (no β-glycerophosphate) was added to the cultures,                         
 
Figure 2: Scanning electron micrographs of two 
cell populations. (A) the transfected cells on day 
1; (B) the non-transfected cells on day 1; (C) the 
transfected cells on day 16; (D) the non-
transfected cells on day 16 
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still at day 16, a noticeable amount of mineralized extracellular matrix was observed in the 
cultures of transfected cells (Figure 2 C). In contrast, the control cells only formed a confluent 
layer without any obvious sign of mineralization (Figure 2 D). 
 
3.4 Real-Time Quantitative PCR 
Expression levels of mRNA for Alp, ColI, OC, Bsp, Dspp, and Dmp1 were compared on 
day 1, 4, 8 and 16. mRNA expression levels of cells before gene transfer (day 0), were set as 
baseline control (relative expression value, 100%). Results showed that Alp was gradually up-
regulated in transfected cells, about 0.46-, 2.1-, 7.8-, and 2.9-fold on day 1, 4, 8, and 16. In 
contrast, non-transfected cells showed no up- or down-regulation of Alp at these days (Figure 
3 A). Col I showed up-regulation for the transfected cells only at day 4 (3-fold) (Figure 3 B). 
OC showed some up-regulation at day 8 (7.4-fold), and 16 (24-fold) in transfected cells, and 
minimal increase in non-transfected cells (Figure 3 C). Bsp also revealed upregulation of 
transfected cells at day 4 (2.1-fold), 8 (3.9-fold), and 16 (2.7-fold) (Figure 3D). The 
expression of Dspp and Dmp1, two dentin specific markers, showed almost similar profiles. 
They were down-regulated on day 1 (0.19- and 0.26-fold). At day 4, Dmp1 showed 
upregulation in transfected cells, while Dspp showed no differences. At day 16, both genes, 
Dspp and Dmp1, were up-regulated, about 4.6- and 2.4-fold (Figure 3 E,F).  
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Figure 3: Representative curves of the mRNA levels of Alp (A); collagen type I (B); OC (C); Bsp (D); 
Dspp (E); Dmp1 (F) quantified during 16 days. Cells were from two cell fractions. 
 
3.5 Gene Expression Profiles in Oligo-Microarray  
The Oligo GEArray Rat osteogenesis microarray profiled the expression of 113 key genes 
involved in osteogenic differentiation. This system was used to compare the multiple gene 
expression profiles representative of the transfected cells vs. non-transfected cells at day 8, 
compared to the control cells at day 0. Table 2 showed the up- or down-regulation of the 
different functional genes. Only a 2-fold change (or more) in signal density was defined to be 
a relevant change in gene expression level. The number of functional genes in that was 
upregulated in the transfected cells compared to non-transfected cells, was 36 (Table 3). For 
the downregulated genes, this number was 15. Several genes, belonging to the categories of 
transcription factors and regulators, growth factors, extracellular matrix, and cell proliferation, 
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i.e. Twist2, Csf3, Fgf3, Col5a1, Itga2, Smad4, and Vcam1, were down-regulated in the 
transfected cells. The results showed that genes involved in skeletal development, bone 
mineral metabolism, cell growth and differentiation, ECM molecules, cell adhesion molecules, 
and transcription factors and regulators were more up-regulated in transfected cells compared 
to control and non-transfected cells (Table 2). Especially, Bglap2(Bone gamma-
carboxyglutamate protein 2), Bmpr1a (Bone morphogenetic protein receptor, type 1A), 1b, 
and 2, Biglycan, Anxa5, Bmp1 to 7, Col4a1, Matrix Gla protein, Msx2 (Msh homeo box 
homolog 2), and Ameloblastin showed high upregulation in transfected cells compared to 
non-transfected cells (Table 3). 
 
4. DISCUSSION 
Gene therapy has shown potential as a strategy for dental tissue engineering. In previous 
studies, Bmp7 and Bmp11, two members of BMP family, have been applied for in vitro gene 
therapy, and resulted in reparative dentin formation in vivo.21,22 However, no study so far  
investigated the differentiation efficacy of Bmp2 gene transfected dental pulp stem cells. Our 
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current study showed that STRO-1 selected rat DPSCs could be transfected with AdBMP-2, 
and that the transfected cells secreted human BMP-2 in high levels (≈ 102 ng/ml) after 48 
hours. Evidently, BMP-2 accumulated in this study to a functional concentration to induce 
cell differentiation in vitro.14,23,24 Although, only the BMP-2 protein expression at 48 hours 
was tested, other studies showed that the adenovirus had also the ability to mediate high levels 
of gene expression in cells for incubation times of more than 3 weeks.25  
Previous studies indicated that an adenovirus dose of 107 particle units or an MOI of over 
50 can provoke a cytotoxic response to the infected cells.26,27 In our study, the transfected 
cells showed an exponential growth, although there was a small delay for cell proliferation in 
the early phase. This delay can be due to a hampering effect of the transfection, or due to the 
inverse relationship between proliferation and differentiation. When cells are more 
proliferative then the differentiation of the cells is declined, and vice versa.28 
ALP is a prerequisite for the differentiation of dental pulp in vivo. In our study, transfected 
DPSCs showed significantly higher ALP activity rates compared to non-transfected cells, 
which was analogue to cells under the influence of a standard osteogenic medium.4 The real-
time PCR results confirmed the up-regulation of ALP expression. However, the expression of 
mRNA is always prior to protein expression, and thus it is well explainable that mRNA 
expression of ALP reached a peak on day 8, whereas ALP activity in the biochemical assay 
showed a peak value at day 16. Both calcium content and SEM observation demonstrated 
more calcified matrix deposition for transfected cells. The transfected cells showed the ability 
to form multilayers and mineralized nodules on a smooth surface in vitro, even without the 
addition of an external source of phosphate.  
Collagen type I is the predominant protein and the basis for dentin repair. Some 
noncollagenous proteins in dentin or bone include OC and BSP. Besides, DSPP is the major 
part of noncollagenous proteins in dentin, and plays a crucial role during dentin 
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mineralization.29 DMP-1 is another specific protein in dentin, and is a candidate gene for 
dentinogenesis imperfecta.30 Although the different genes showed different mRNA expression 
profiles, their expression was more or less increased after AdBMP-2 transfection compared to 
non-transfected cells. This change was comparable to that of DPSCs under osteogenic culture 
or treated with rhBMP-2 protein.2,4,14 The expression of these markers offers strong evidence 
that DPSCs differentiate into odontoblasts by the presence of BMP-2 protein originated from 
the adenoviral-mediated BMP-2 transfer. 
In previous studies, representative gene expression profiles and functional classifications 
were compared between human DPSCs and mesenchymal stem cells from bone marrow 
(MSCs) by using a cDNA microarray system containing over 4000 or 12814 human 
genes.31,32 Human DPSCs and MSCs were found to have similar levels of gene expression for 
more than 4000 known genes. A few genes, including Collagen type XVIII α1, insulin-like 
growth factor-2 (Igf2), discordin domain tyrosine kinase 2, and cyclin-dependent kinase 6, 
were more highly expressed in DPSCs.31 Further, the studies revealed that the expression 
levels for several genes, which belong to cell division, cell signal, cell structure, and 
metabolism, are regulated differently between both cell types, upon prolonged culturing.32 In 
our present study, the results of the functional oligo-microarray for rat osteogenesis showed 
that the transfected cells contained higher expression levels in functional genes. These genes 
were divided into several functional categories, including skeletal development, bone mineral 
metabolism, cell growth and differentiation, extracellular matrix (ECM) molecules, cell 
adhesion molecules, and transcription factors and regulators. The high expression levels of 
Alp, Dspp and Dmp1 in the transfected cells confirmed the PCR and ALP activity results of 
our study. Furthermore, BMP-2, -4, -6, and -7, which are strong promoters for osteogenesis, 
mineralization formation, and tooth morphogenesis,17,33 showed markedly increased 
expression levels compared to the non-transfected cells. The higher expression levels for the 
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BMP receptors (Bmpr1a, Bmpr1b and Bmpr2) in transfected cells are probably a logical result 
of the increase in secreted BMP-2. Further, the increase in protein expression of BMP-2 
results in signals from the plasma membrane to the nucleus requiring several SMAD 
proteins.34 This could explain the upregulation for Smad 1, 2, 3, and 7 in the transfected cells. 
In the present study, also Msx2 was upregulated after transfection. This is noticeable since Shi 
et al. described that Msx2 was expressed at a low levels by both DPSCs and BMSCs.35 The 
BMP-Msx pathway mediates reciprocal interactions between the epithelium and mesenchyme 
during early bone and tooth development. BMP-4 is known to induce Msx2 expression in 
cultured dental mesenchyme.36  
Two final genes that were interestingly upregulated were Bglap2 and Ambn. First, Bglap2, 
encoding a highly conserved protein associated with mineralized bone matrix and secreted by 
calcified tissues, was highly expressed in transfected cells. Second, Ambn encodes 
ameloblastin, that acts as a structural component of tooth enamel matrix.35 This gene 
manifested up-regulation only in transfected cells. Generally, more active odontogenesis-
related genes were undoubtedly found in the transfected cells, meaning that these cells were 
more directed towards the odontogenic pathway.      
In summary, rat STRO-1 selected dental pulp stem cells were successfully transfected with 
AdBMP-2. Transfected cells underwent effective induction towards the odontoblast 
phenotype compared to non-transfected cells, even in medium without externally added 
substitutes (dexamethasone, β-glycerophosphate). The results of this study were in accordance 
with our hypothesis, and the here established combination of more homogeneous cell 
population with gene transfection could be a strategy to improve the clinical efficacy of 
DPSCs for hard tissue engineering. To prove that presence of BMP is a denominator for 
odontogenic differentiation, and thus to reconcile previous discordant reports, animal studies 
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are necessary. Therefore, further evaluation should be performed in three-dimensional 
scaffolds in vitro as well as in vivo.   
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1. INTRODUCTION 
It is generally assumed that dental pulp stem cells (DPSCs) are the optimal candidate for 
dental tissue regeneration.1-4 However, various studies as performed in our laboratory showed 
that obvious hard tissue formation in subcutaneously installed synthetic scaffolds loaded with 
DPSCs did not occur.5,6 This observation means a limitation of the application of DPSCs for 
clinical purposes, and implies the necessity to optimize the applied stem cell technology. In 
view of this we have to notice that earlier studies indicated that a more homogeneous strain of 
DPSCs can be isolated by immunoselection using the mesenchymal stem cell marker STRO-
1. 4,7-9 STRO-1 selected cells possess enhanced ability to form mineralized extracellular 
matrix (ECM), as well as for development towards other differentiation pathways.4,9-11 
An additional strategy to enhance the efficacy of stem cell application can be to transfect 
the cells with certain genes. Especially the gene for bone morphogenetic protein 2 (Bmp2) 
seems relevant, as in vivo studies have already shown the BMP-2 protein to effectively 
promote hard tissue formation by DPSCs and bone cells.12-14 Gene therapy abolishes the need 
of using external stimulating growth factors or hormones like dexamethasone.15 Adenovirus, 
well known as gene vector, have already been applied in clinically relevant gene therapy.16 
An adenoviral-mediated human Bmp2 gene has been transfected into STRO-1 selected rat 
DPSCs, and also showed its ability to effectively promote odontogenic action.17 Thus, as an 
optimized approach, the combinated application of cell selection with gene therapy may be 
most attractive for dental pulp cell-based tissue engineering. 
Therefore, in this study, STRO-1-selected DPSCs transfected with Bmp2 gene were loaded 
onto ceramic scaffolds. After subcutaneous implantation, hard tissue formation was evaluated. 
We hypothesized that only Bmp2-transfected cells have hard tissue formation capacity in this 
in vivo model, when no other stimulating culture supplements are used. 
 
 120
                                                                                                                                     Chapter 6 
2. MATERIALS & METHODS 
2.1 Cell and Gene Transfer 
Rat DPSCs were selected on STRO-1 as described before.9 The selected cells were 
expanded to the 10th passage in minimal essential medium-α (α-MEM; GIBCO-BRL, Breda, 
The Netherlands) with 10% fetal calf serum (FCS; GIBCO-BRL) and gentamycin (50 μg/mL; 
Sigma). STRO-1 positivity after the expansion step was confirmed. 
A replication-deficient adenoviral vector carrying the human Bmp2 gene, AdBMP-2 was 
used.17 STRO-1-positive cells were seeded at 3x104/cm2 and after 24 hrs, Ad-BMP2 was 
added at multiplicity of infection of 100 for 4 hrs. 
 
2.2 Cell Seeding  
Sintered ceramic discs (Camceram®, CAM Implants BV, Leiden, the Netherlands) were 
used of diameter 6mm, thickness 3mm, hydroxyapatite/tricalcium phosphate (HA/TCP) ratio 
60/40, and volumetric porosity 90%. The discs were sterilized at 121ºC for 15 min, and pre-
wetted in culture medium overnight. 
Two days post transfection, scaffolds were submerged in a suspension of 5.0x106 cells/ml 
while gently rotating at 6 rpm for 3 hrs. For every 6 scaffolds, 1 ml cell suspension was used. 
Subsequently, the scaffolds were transferred to 24-well plates. Non-transfected cells were 
used as control. 
 
2.3 In Vitro Study 
Cell-scaffold complexes (n=3) were assessed on day 1, 4, and 8 post-seeding on total DNA 
content, and alkaline phosphatase (ALP) activity as described before.18 For scanning electron 
microscopy (SEM, n=2) samples were fixed in 2% glutaraldehyde, dehydrated in ethanol, 
dried in tetramethylsilane (Merck, Germany), and sputtercoated with gold. 
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2.4 Implantation Study 
Cells were seeded as above, and cultured for 4 days. Eight samples of each group and 
implantation time were used. Twelve 10-week-old BALB/c immunocompromised nude mice 
were used (approval DEC2007187). National guidelines for the care of laboratory animals 
were obeyed. Surgery was performed under general isoflurane anaesthesia. The backs of the 
mice were washed and disinfected. On each flank two subcutaneous pockets were created. To 
avoid cross-over effects of the virus matter, each mouse received always 4 implants of the 
same group (transfected or non-transfected). The skin was closed using staples. Samples were 
retrieved at 1, 4, and 12 weeks post-implantation. 
 
2.5 Light Microscopical  
Half of the samples for each group were fixed in formalin, dehydrated in a series of 
ethanol, and embedded in methylmethacrylate (MMA). Three thin transversal sections 
(10µm) of each tissue block were made and stained with methylene blue/basic fuchsin.19  
Image analysis was performed  using Leica® Qwin Pro (Leica, Wetzlar, Germany). The 
areas of the ceramic and hard tissue were detected. The outline of the implant area minus the 
area of the ceramic was designated as the region of interest (ROI). Then, the ratio of hard 
tissue to the ROI was calculated (Castano-Izquierdo et al., 2007).20 
 
2.6 Real-time Quantitative PCR 
The remaining 4 samples of each group were used for PCR analysis. After retrieval the 
fibrous tissue capsules and other surrounding tissues were removed. The scaffolds and 
interstitial tissues were cut into small pieces, and transferred to liquid nitrogen immediately. 
Total RNA of each sample was prepared with a Qiagen RNEasy kit (QIAGEN, Venlo, The 
Netherlands). Then, 1 μg of total RNA was used to perform the reverse transcriptase reaction. 
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The obtained cDNA was used as a template in PCR. The odontogenic differentiation of cells 
was monitored by analyzing the specific markers osteocalcin (OC), bone sialoprotein (BSP), 
dentin sialophosphoprotein (DSPP), and dentin matrix protein 1 (DMP-1). GAPDH was used 
as house-keeping gene to normalize RNA expression. The primers were described 
previously.17 Real-time PCR was performed using the SYBR Green PCR kit (Eurogentec, 
Liege, Belgium) and controlled in a spectrofluorimetric thermal iCycler® (BioRad, The 
Netherlands). After the PCR run, the Ct-value showed how many cycles were necessary to 
obtain a certain level of fluorescence. Amplification efficiency of different genes was 
determined relative to GAPDH (ΔCt = Ct gene – Ct GAPDH). The mRNA in each sample 
was calculated by the comparative ΔΔCt (ΔCt gene – ΔCt control) method.21 Each 
measurement was assessed in triplicate. 
 
2.7 Statistical Analysis 
Statistical significance was evaluated at p<0.05 using one way-ANOVA and Tukey testing. 
 
3. RESULTS 
3.1 In Vitro Analysis 
Significant differences in total DNA content was observed between the two groups; The 
non-transfected cells increased in number over 8 day period. In contrast, the transfected group 
showed lower cell numbers for all incubation times, and a decrease in DNA content from day 
4 to 8. The ALP activity gradually increased from day 1 to 8 for both groups. However, the 
transfected group showed significantly higher levels at all incubation times (Figure 1A,B).  
SEM observation of the day one specimen showed that cells had adhered and spread on the 
surfaces of the scaffolds. There were no obvious morphological differences between the two 
groups. At day 4, as confirmed by additional energy dispersive spectroscopy, a noticeable 
 123
Hard Tissue Formation by BMP2-transfected Pulp Stem Cells 
amount of mineralized nodules appeared on cell/scaffold complexes in the transfected group 
only (Figure 2). 
 
 
Figure 1: (A) The proliferation characteristics; (B) ALP activity. The bars represent the means ± SD 
(n=3). Transfected compared to the non-transfected at the same implantation period: * P<0.05, ** 
P<0.01; transfected on day 4 or 8 compared to day 1: # P<0.05, ## P<0.01; non-transfected on day 4 or 8 
compared to day 1: # P<0.05, ## P<0.01; transfected on day 8 compared to day 4: ∆ P<0.05, ∆∆ P<0.01; 
non-transfected on day 8 compared to day 4: ∆ P<0.05, ∆∆ P<0.01. 
 
  
Figure 2: Scanning electron micrographs
of both groups. (A) transfection group on 
day 1; (B) non-transfection group on day 
1; (C) transfection group on day 4; (D)
non-transfection group on day 4. Arrows 
indicate some of the calcified nodules. 
 
3.2 In Vivo Analysis 
All mice appeared to be in good health throughout the test period. After sacrifice, all 
implants were retrieved successfully. There were no symptoms of inflammation at the 
implantation sites.  
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3.3 Light Microscopic Evaluation 
Histological observation indicated that all implants were surrounded by a very thin fibrous 
tissue capsule composed of 4-6 cell layers, closely following the perimeter of the scaffold. 
Inflammatory cells were only sporadically present in this capsule.  
For the 1-week implants, the macro-pores of scaffolds were filled with fibrous tissue. No 
evident hard tissue formation occurred in both groups (Figure 3A,B). However, at higher 
magnification, the transfected group showed large amounts of a red-stained granular deposit 
on the surface of the scaffold pores (Figure 4A).  
At 4 weeks of implantation, all implants seeded with transfected DPSCs showed obvious 
hard tissue formation (Figure 3C). The newly formed hard tissue was stained deep red by the 
basic fuchsin and resided mainly along the surface of the pores. At higher magnification 
(Figure 4B,C), distinct concentric lamellae of mineralized matter were observed with 
entrapped osteocyte-like cells, and osteoblast-like cells lying orderly arranged at the pore 
surface. In addition always a bone-marrow-like hematopoietic tissue was associated with the 
newly formed hard tissue. The newly formed tissues seemed distributed evenly throughout the 
scaffold. In the samples loaded with non-transfected DPSCs, no hard tissue formation was 
found (Figure 3D). Only an orderly arranged thick fibril-like ECM with multiple-layers of 
cells was seen, organized parallel to the pore surface (Figure 4D). 
After 12 weeks of implantation, the transfected group upon visual inspection showed 
enhanced hard tissue formation compared to the 4-week group (Figure 3E). The non-
transfected group still showed only small amounts of hard tissue (Figure 3F). 
 
3.4 Histomorphometry 
Both at the 4 and 12-week implantation periods significantly more hard tissue formation 
had occurred in the transfection group (17 ± 4.2% and 33 ± 7.3% of pore area, respectively)    
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Figure 3: General overview of the implants 
of 1, 4, and 12 weeks (methylene blue 
basic/fuchsin staining) from transfection or 
non-transfection group. (A) transfected at
1 week; (B) non-transfected at 1 week; (C)
transfected at 4 weeks; (D) non-transfected 
at 4 weeks; (E) transfected at 12 weeks; 
(F) non-transfected at 12 weeks; Scale bar 
is 400 µm (original magnification 2.5X). 
 
Figure 4: Histology and morphology of implants at a high magnification (methylene blue basic/fuchsin 
staining). (A) transfected at 1 week, note that the section showed large amounts of a granular-like mineral 
deposit around the osteoblast-like cells, as seen at the surface of the macro-pores of the scaffolds (arrow) 
(original magnification 40x), bar size is 25 µm;  (B) transfected at 4 weeks, (original magnification 20X), 
bar size is 50 µm; (C) transfected at 4 weeks, note the orderly array of osteoblast-like cells on the surface 
of bone-like matrix (arrow) (original magnification 40X), bar size is 25 µm; (D) non-transfected at 4 
weeks, note the multiple-layers of cells orderly arranged along the pore surface (arrow), however lacking 
bone-like tissue formation (original magnification 40X), bar size is 25 µm. 
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compared to the non-transfected group (0 and 2 ± 1.8%, respectively). Within the transfected 
group hard tissue formation increased significantly from the 4 to the 12-week period. 
 
3.5 Real-Time PCR 
Strikingly, the expression of the four measured genes always showed similar profiles 
(Figure 5A-D). Both groups revealed the same expression profiles for the measured genes, 
with overall expression increasing significantly in time. The transfected group without 
exception demonstrated significant up-regulation of expression compared to the non-
transfected group. 
 
   
      
Figure 5: Curves of the mRNA levels of OC (A); BSP (B); DSPP (C); DMP-1 (D); quantified for the in 
vivo specimens. The bars represent the mean ± SD (n = 3). Transfected compared to non-transfected with 
the same implantation period: * P<0.05, ** P<0.01; transfected at week 4 or 12 compared to week 1: # 
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P<0.05, ## P<0.01; non-transfected at week 4 or 12 compared to week 1: # P<0.05, ## P<0.01; 
transfected at week 12 compared to week 4: ∆ P<0.05, ∆∆ P<0.01; non-transfected at week 12 compared 
to week 4: ∆ P<0.05, ∆∆ P<0.01. 
 
4. DISCUSSION 
In our previous study, the differentiation efficacy of BMP-2 gene transfeced DPSCs was 
approved in vitro.17 The purpose of this study was to evaluate their potential for in vivo hard 
tissue regeneration. In general, Bmp transfection proved to be an extremely effective strategy 
to promote hard tissue formation. However, the tissue that was formed upon visual inspection 
did not appear to be dentin, but based on its morphological appearance more resembled bone. 
In our study set-up, specifically cell-culturing conditions were chosen without the external 
addition of dexamethasone, as the biological reaction of the osteogenic supplements may 
partially mask the benefit of BMP-2 produced by the genetically modified cells.15 In previous 
research, Bmp2 transfected DPSCs underwent effective induction towards the odontoblast 
phenotype in vitro, even in non-osteogenic medium.17 Results of the in vitro part of our 
current study corroborated these findings. Further, ALP activity showed significantly 
enhanced rates. These results were analogous to the influence of a standard dexamethasone-
containing medium on the growth and differentiation of DPSCs.5,6,17  
A porous calcium phosphate ceramic carrier was selected as scaffold material. This 
material was also used in other studies for hard tissue regeneration, because of its 
biocompatible character and the ability to support the differentiation of bone and dentin 
forming cells.5,11,22 Also the pre-culture time before implantation was based on our previous 
experience. There is an inverse relationship between cell proliferation and differentiation.20,23 
Inadequate pre-implantation culture periods result in very limited amounts of hard tissue 
formation after implantation, whereas 4 days of odontogenic stimulation drives DPSCs to the 
preferable stage, with an optimal balance between proliferation and differentiation.11 A final 
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technical remark regarding our study design is that no full randomization was applied for the 
in vivo implantation. Adenoviral-transfected samples might influence neighboring samples 
placed in the subcutaneous area of a small animal like the mouse. Thus, only one pre-
treatment group per mouse was used to avoid cross-over effects. Still, multiple mice were 
used for each group, without noticeable intra individual differences in reaction. 
For our mRNA expression analyses OC, BSP, DSPP, and DMP-1 were chosen as markers 
for the odontogenic phenotype. OC and BSP are usually regarded late markers for osteoblast 
differentiation.24 DSPP is the major dentinal non-collagenous protein and essential for dentin 
mineralization.25 DMP-1 is also specific for dentin and is mostly known as candidate gene for 
dentinogenesis imperfecta.26 Previously it was shown that upon subcutaneous implantation of 
DPSCs all these four genes were found highly expressed, however without tissue 
mineralization actually occurring.5,6 The expression levels could be increased by adding 
BMP-2 protein, and dexamethasone in the cell culture phase, which upon implantation 
elicited 36 ± 9% of newly formed hard tissue in the pore area.11 This is statistically 
comparable to our current result with the transfected cells (33 ± 7% of pore area). 
The expression of DSPP suggests a distinct developmental functionality in vivo.27 Previous 
literature has shown that DPSCs-mixed with HA/TCP powder can regenerate a dentin-pulp-
like structure in ectopic implantation sites. DPSC transplants are characterized by a well-
defined layer of aligned odontoblast-like cells, with their processes oriented in the same 
direction and extending into tubular structures within newly generated dentin.1,2 However, in 
the current study only a bone-like hard tissue formation was observed, with distinct concentric 
lamellae, osteocyte-like cells, and bone marrow-like hematopoetic tissue, although Dspp and 
Dmp1 were upregulated. The absence of dentin-like features in favor of a bone-like 
morphology is striking, since the loaded cells are derived from dental pulp, a tissue which in 
situ forms dentin only. This can be result of the inductive supplements as used. In dental 
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tissue engineering research the “odontogenic” medium formulations are chosen similar to the 
osteogenic supplements known to promote osteoblast differentiation from bonemarrow.  
Hence, neither dexamethasone nor BMP-2 are strictly to be defined as “odontogenic” factors. 
A second explanation for the absence of dentin morphological features can be the 
consequence of the micro-morphology and/or chemical characteristics of the used HA/TCP 
ceramic scaffold.5 Improved scaffold designs in composition as well as morphology can 
facilitate the formation of more natural looking dentinal tissue constructs.28 
 
 
5. CONCLUSIONS 
STRO-1-selected dental pulp stem cells can be genetically modified with the hBMP-2 
gene. Compared with non-transfected cells, more effective induction towards the odontoblast 
phenotype, and abundant hard tissue after subcutaneous implantation is achieved, even 
without supplements like dexamethasone. The combination of homogeneously STRO-1 
selected DPSCs with Bmp transfection shows great potential for therapeutic application. 
However, a remaining challenge is how to obtain a more biomimetic dentin-like appearance. 
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1. INTRODUCTION 
In tissue engineering, gene therapy is used as a means of delivering genes locally to 
somatic cells encoding for proteins like growth factors, transcription factors, or extracellular 
matrix molecules with a resulting therapeutic effect. The applied genes can stimulate or 
induce a natural biological process by expressing bioactive molecules that are involved in the 
regenerative response of the tissue.1 Gene therapy can be a valuable tool to avoid the 
limitations of local delivery of growth factors, including short half-life, large dose 
requirement, high cost, a need of repeated applications, and poor distribution.2 In our previous 
study, an adenoviral- mediated human Bmp2 gene has been transfected into STRO-1 selected 
rat dental pulp stem cells (DPSCs), and showed its ability to effectively promote odontogenic 
action.3 However, the clinical application of an adenovirus is not advisable as it results in 
endogenous recombination, oncogenic effects, and toxic immunological reactions leading to 
potential serious complications.4,5 For this reason, a number of non-viral vectors have been 
explored. Two types of classic non-viral vectors are liposomal formulations, and cationic 
polymers. Unfortunately it has been observed that, in addition to cytotoxicity, these vectors do 
not always lead to satisfactory efficacy of gene expression in the cells. The reasons may be 
due to low endosomal escape, no protection of DNA from nuclease degradation, and 
inefficient nuclear uptake.6-8  
The application of inorganic nanoparticles with entrapped DNA is a new field for non-viral 
transfection, and is expected to overcome the limitations mentioned above. The advantages of 
these vectors are the ease of manufacture, low costs, stability, low immunogenicy, and low 
risk for the plasmid to be inserted into the host cell genome. In literature, plasmid DNA 
(pDNA)-loaded calcium phosphate nanoparticles have already been demonstrated to be highly 
efficient for transfection in the Hela cell line.9,10  
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The osteoinductive potential of recombinant human BMP2 has already been confirmed in a 
clinical study.11 In our study recombinant human BMP-2 gene was used for the transfection 
because it can stimulate differentiation of adult dental pulp cells into odontoblasts, and it also 
plays a role during the various stages of the formation of hard skeletal and dental tissue in 
bone and teeth.12-14 Furthermore, for our dental tissue engineering purposes, dental pulp-
derived adult stem cells (DPSCs) were used as these responding stem cells in nature. A 
hierarchy of DPSCs causes the variable behavior of these cells in vitro, and results in a low 
therapeutic potential in vivo.15,16 STRO-1+ DPSCs were chosen because selection with this 
marker increased the ability of osteo/odontogenic differentiation, as well as development 
towards other differentiation pathways.3,17,18  
In this study, we intended to transfect STRO-1 selected rat DPSCs with pDNA entrapped 
into calcium phosphate nanoparticles. We hypothesized that calcium phosphate nanoparticles 
would result in a relatively high transfection efficacy, and that the secreted BMP-2 would be 
effective in odonto-inductive action. 
 
2. MATERIALS & METHODS 
2.1 Preparation of Plasmid DNA Loaded Calcium Phosphate Nanoparticles 
A recombinant green fluorescent eukaryotic cell expressing plasmid carrying human Bmp2 
gene (pEGFP-BMP2), was used in the current study. The preparation of pDNA-loaded 
calcium phosphate nanoparticles followed the protocol of Bisht et al.10 The basic method was 
as follows: 0.1 M AOT (Surfactant, Aerosol OT, i.e. bis (2-ethylhexyl) sulphosuccinate) 
solution in hexane (Sigma) was prepared. In 25 ml of AOT in hexane, 70μl aqueous solution 
of 1.36 M calcium chloride and aqueous solution of 2.94 μg of pDNA, were added by 
continuous stirring overnight to form a micro-emulsion “A”. In another 25 ml of AOT 
solution, 50 μl of 0.2 M Tris–HCl buffer (pH 7.4), 70 μl aqueous solution of 0.35 M Na2HPO4 
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and an aqueous solution of 2.94 μg of pDNA, were dissolved by continuous stirring overnight 
to form micro-emulsion “B”. Before stirring both micro-emulsions, excess water was added to 
make the total volume of water to 450 μl to adjust wo (the molar ratio of water to AOT) at 10. 
Then, micro-emulsion “B” was added to “A” at an extremely slow rate (5 ml per hour) with 
continuous stirring at 4 ◦C, and was kept in the same condition overnight. Subsequently, 
hexane was carefully removed from the resulting solution after centrifuging 30 min at 5000 
rpm at 4 ◦C. The sediment was dissolved in 10 ml of absolute ethanol by vortexing, followed 
again by centrifugation. After three of such cycles, the pelleted nanoparticles were dispersed 
in Milli-Q water at 4 ◦C by vortexing. Finally, the dispersed nanoparticles were lyophilized to 
dry powder (yield ~ 1 mg). 
 
2.2. Morphology and Characteristics of the Nanoparticles 
2.2.1. TEM 
To evaluate the size of the nanoparticles, one drop of aqueous dispersion of the particles 
was put on a forvmar coated copper grid and air dried at room temperature. The dried grid 
was examined under a JEOL 1101 transmission electron microscope (TEM).  
 
2.2.2. Gel electrophoresis  
In order to check the protection of DNA in the nanoparticles from external Dnase 
degradation, 20 μl aqueous dispersion of calcium phosphate/DNA nanoparticles (containing 1 
μg pDNA) prepared by the above method was incubated with 5 μl of DNaseI (5 mg/ml) at 
37◦C for different time intervals (0, 0.5 and 1h), and then loaded in a 1% agarose gel. As 
positive and negative controls, 10 μl free pDNA was either loaded alone or after incubation 
with DNaseI. 
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2.2.3. Entrapment Efficiency 
The entrapment efficiency of DNA attached to the nanoparticles was evaluated by 
dissolving the particles in acidic buffer (pH 3.0) and incubating overnight. The amount of 
pDNA released from the nanoparticles ([pDNA]r) was estimated spectrophotometrically by 
measuring the OD at λ = 260 nm. The entrapment efficiency was then calculated from the 
amount of DNA originally added in the solution ([pDNA]0), using the equation E% = 
[pDNA]r/[pDNA]0 ×100. 
 
2.3. In Vitro Transfection Studies 
2.3.1 Cell Culture 
Rat DPSCs (10th passage) were selected on the stem cell marker STRO-1 by FACS as 
described before,17 and expanded in minimal essential medium-α (α-MEM; GIBCO-BRL, 
Breda, The Netherlands) supplemented with 10% fetal calf serum (FCS; GIBCO-BRL) and 
gentamycin (50 μg/mL; Sigma).  
 
2.3.2. Determination of Transfection Efficiency 
The cells were seeded in 24-well plate at a density of 2×104 cells in 1 ml of culture medium 
per well. Upon reaching 80% confluency, cells were used for transfection. Then, 0.3 ml of 
pEGFP-BMP2-loaded calcium phosphate nanoparticles in α-MEM without FCS and 
antibiotics (total amount of pDNA ~ 0.5μg) was added in each well. After incubation at 37◦C 
for 4 hrs, the transfection complex was replaced with fresh α-MEM containing 10% FCS and 
antibiotics. Forty-eight hrs post-transfection, cells were detached to detect green fluorescence 
with fluorescence microscopy to calculate the temporary transfection rate. Simultaneously, 
the supernatants were collected on day 2, 4, 6, 8, and 10 after transfection. These samples 
were used to measure the concentration of recombinant human BMP-2 by using a BMP-2 
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ELISA kit (Quantikine®, R&D System, Inc. Minneapolis, MN) (n = 6). Also, at day 1, 4, 8, 
and 16 after transfection the proliferation rates of the cells, as measured by the total DNA 
content (n = 6), were assessed with a PicoGreen dsDNA quantification kit (Molecular Probes, 
Leiden, The Netherlands).19 The commercial transfection reagent LipofectamineTM 2000 
(Invitrogen, Gaithersburg, MD, USA) was used as control.  
The bioactivity of hBMP-2 produced from transfected cells was assessed by ALP activity 
upregulation using the cell line W20-17 as reported previously.20 Briefly, 48 h post-
transfection, the supernatants were collected and filtered. Then, these conditioned media were 
transferred to 80% confluent W20-17 cells (n = 6). After additional 48 hrs incubation, a lysate 
was prepared to measure ALP activity of the W20-17 cells.20  
 
2.4. Three-Dimensional Scaffold Culture 
Titanium fibre mesh (Bekenit, SaitamaKen, Japan) was used as a 3-D scaffold. The fibre 
diameter was 45 µm. The volumetric porosity of the total mesh was 86%, and the weight was 
400 g/m2. A titanium fibre mesh sheet was cut into discs of 6 mm in diameter and 1 mm in 
thickness, and then scaffolds were sterilized by autoclaving. 
 
2.4.1. Cell Seeding 
 All scaffolds were pre-wetted in α-MEM medium with 10% FCS and 50 µg/ml gentamycin 
overnight. Forty-eight hrs post- transfection, STRO-1 selected DPSCs were seeded onto the 
scaffolds by incubating the scaffolds in a suspension of 1.0x106 cells/ml while gently rotating 
at 6 rpm for 3 hrs. For every 6 scaffolds, 1 ml cell suspension was used. Subsequently, the 
scaffolds were put in 24-well plates for culturing with α-MEM supplemented with 10% FCS, 
10 mM sodium β-glycerophosphate, 10-8 M dexamethasone, L-ascorbic acid (50μg/mL), and 
gentamycin (50μg/mL). The non-transfected cells were used as control, and cultured in the 
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same osteogenic medium as above, or in non-osteogenic medium (α-MEM supplemented with 
10% FCS and 50μg/mL gentamycin.). Culture media were replaced at 3-day intervals.  
 
2.4.2. Cell Proliferation, Alkaline Phosphatase Activity and Calcium Content 
On day 1, 4, 8, 16 and 24 post-seeding, the proliferation rates of cells, as measured by total 
DNA content (n = 3), were assessed. The same samples as used above were also used to 
measure alkaline phosphatase (ALP) activity. Twenty μL of 0.5 AMP buffer (Sigma) was 
added to 80 μL of the samples or standards. Next, 100 μL of substrate solution was added and 
the mixtures were incubated at 37 ◦C for 1 h. ALP activity was measured at 405nm, using an 
ELISA microplate reader (Bio-Tek Instruments Inc., USA). On day 4, 8, 16 and 24 after 
seeding, the calcium content of the samples (n = 3) was measured by the o-cresolphthalein 
complexone (Sigma) method.19 
 
2.4.3. Scanning Electron Microscopy (SEM) 
On day 1, 8, and 24 after cell seeding, scaffolds were rinsed with filtered PBS, and fixed in 
2% glutaraldehyde for 5 min, dehydrated in graded series of ethanol, and dried in 
tetramethylsilane (Merck, Germany). Gold was sputtered on the samples just before SEM 
analysis. The specimens were examined with a JEOL 6310 SEM, at an accelerating voltage of 
10 kV. 
 
2.4.4. Real-Time Quantitative PCR 
On day 1, 4, 8, and 16 after cell seeding, total RNA of every sample was prepared with 
Qiagen RNEasy kit (RNeasy kit, QIAGEN, Venlo, The Netherlands). Then, 1 μg of total RNA 
was used to perform the reverse transcriptase (RT)-reaction. The obtained cDNA was used as 
a template in PCR. The odontogenic differentiation of cells was monitored by specific 
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markers, ALP, collagen type I (Col I ), osteocalcin (OC), dentin sialophosphoprotein (DSPP) 
and dentin matrix protein 1 (DMP-1). GAPDH was used as house-keeping gene to normalize 
RNA expression (Table 1). 
Real-time PCR was performed using SYBR Green PCR kit (Eurogentec, Liege, Belgium) 
and controlled in a spectrofluorimetric thermal iCycler® (BioRad, The Netherlands). After 
the real-time PCR run, the Ct-value showed how many PCR cycles were necessary to obtain a 
certain level of fluorescence. Amplification efficiency of different genes was determined 
relative to GAPDH as an internal control (ΔCt = Ct gene – Ct GAPDH). The mRNA in each 
sample was calculated by comparative ΔΔCt (ΔCt gene – ΔCt control ) value method. Each 
sample was assessed in triplicate. 
Table 1:  Rat specific primers for real-time PCR 
 Sense primer Antisense primer 
ALP 5’-GCTTCACGGCATCCATGAG- 3’  5’-GAGGCATACGCCATGACGT-3 
OC 5’-GGCTTCCAGGACGCCTACA-3 5’-CATGCCCTAAACGGTGGTG-3’ 
Col I 5’-TGGAATCTTGGATGGTTTGGA-3’ 5’-GCTGTAAACGTGGAAGCAAGG-3’ 
DSPP 5’-CGGTCCCTCAGTTAGTC-3’ 5’-TACGTCCTCGCGTTCT-3’ 
DMP-1 5’- CGTTCCTCTGGGGGCTGTCC -3’ 5’- CCGGGATCATCGCTCTGCATC -3’ 
GAPDH 5’- GAAGGGCTCATGACCACAGT-3’ 5’- GGATGCAGGGATGATGTTCT-3 
 
2.5. Statistical Analysis 
Statistical significance was evaluated using one way-ANOVA with post-hoc Tukey testing 
and P < 0.05 was considered significant. Error bars represent mean ± standard deviation (SD). 
 
3. RESULTS 
3.1. pDNA Loaded Calcium Phosphate Nanoparticles 
After continuous stirring overnight, both the micro-emulsion “A” and “B” showed optically 
clear solutions. In the resulting solution (mixture of “A” and “B”), development of 
translucency implicated nanoparticle formation in the aqueous core of the micro-emulsion 
droplets. The TEM investigation revealed the formation of dense particles with a spherical 
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morphology. The particle size, while well dispersed in water, was in the range of 75-100 nm 
diameter (Figure 1). The resistance of pDNA-loaded calcium phosphate complexes to external 
aggressive DNase attack was demonstrated in gel electrophoresis (Figure 2). Although free 
plasmid DNA could move to the usual position (~ 6 kb) and could also be completely 
digested by external DNase, the plasmid-loaded complexes had hardly moved and still stayed 
at the top of the lanes. One mg of pDNA loaded nanoparticles, in which the original amount 
of applied DNA was 5.88 μg, was used to evaluate the entrapment efficiency of DNA inside 
the nanoparticles. After overnight incubation, the entrapment efficiency (E%) was calculated 
as 97.15% ± 2.04% (n = 4). 
           
Figure 1: Transmission electron micrograph 
(TEM) of pDNA encapsulated calcium phosphate
nanoparticles. 
 
Figure 2: Agarose gel (1%) electrophoresis. 
Lane 1: DNA marker. Lane 2: free pEGFP-
BMP2 DNA (6 kb). Lane 3: pEGFP-BMP2 DNA 
treated with DNase for 0.5 h. Lane 4: pEGFP-
BMP2 loaded calcium phosphate nanoparticles. 
Lane 5: pEGFP- BMP2 loaded calcium 
phosphate nanoparticles treated with DNase for 
0.5 h. Lane 6: pEGFP-BMP2 loaded calcium 
phosphate nanoparticles treated with DNase for 
1h. 
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3.
se in W20-17 ALP activity relative to 
the control group of non-transfected cells (P < 0.01).  
2. In Vitro Transfection Studies 
The successful transfection could be easily traced by green fluorescence protein (GFP). 
Forty-eight hrs post-treatment of nanoparticels, the DPSCs showed the expression of green 
fluorescence, visually demonstrating a similar positive rate to that of cells transfected by 
LipofectamineTM 2000 (Figure 3). The amount of hBMP-2 secreted by transfected rat DPSCs 
was quantitated by ELISA (Figure 4 A). With LipofectamineTM 2000 transfection, the cells 
produced significantly more hBMP-2 on day 2, however on day 8 and 10, the expression of 
hBMP-2 was significantly lower. The DNA results showed significantly higher cell numbers 
in the nanoparticle group for all time points, however the subsequent proliferation was similar 
to the cells transfected with LipofectamineTM 2000 (Figure 4 B). The bioactivity of hBMP-2 
was assessed by the ability of conditioned media to upregulate the ALP activity of the BMP-
2-sensitive W20-17 cell line (Figure 4 C). The medium from rat DPSCs transfected with 
nanoparticle indeed demonstrated a significant increa
 
e 3: Fluorescent micrographs of GFP expression in pEG MP2 transfected rat selected DPSCsFigur FP-B . 
icles group; (B) LipofectamineTM group, (original magnification 10 X). 
3.
 faster 
compared with transfected cells and non-transfected rat DPSCs in osteogenic medium.  
(A) calcium phosphate nanopart
 
3. 3-D Scaffold Culture 
The cell proliferation rates are depicted in Figure 5 A. Analysis of the data showed that the 
proliferation of non-transfected rat DPSCs in non-osteogenic medium was significantly
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Figure 4: (A) ELISA for hBMP-2 concentration in three groups. The bars represent the means ± SD (n=6). 
The calcium phosphate nanoparticle group (NP) compared to LipofectamineTM group (Lipo): * P<0.05, ** 
P<0.01; NP group compared to non-osteogenic group (control): ## P<0.01. (B) The proliferation 
characteristics of two groups. The bars represent the mean ± SD (n=6). NP group compared to lipo group 
(Lipo): * P<0.05, ** P<0.01. (C) The bioactivity of hBMP-2 produced from transfected rat DPSCs 
mediated with nanoparticles 48 h post transfection. Bioactivity was assessed by upregulation of ALP 
activity in W20-17 cells induced by conditional medium incubated with rat DPSCs. The bars represent the 
mean ± SD (n=6). NP group compared to non-osteogenic group (control): ** P<0.01. 
 
However, no significant differences were found between these latter two groups. The ALP 
activity of both cell groups cultured in osteogenic medium increased during 24 days, but 
transfected DPSCs showed significantly higher levels from day 4 compared to non-
transfected cells (Figure 5 B). The non-transfected cultured in non-osteogenic medium always 
demonstrated significantly lower levels of ALP activity (P < 0.01), and only started to 
increase after day 8. The calcium content increased significantly between day 8 and 24 for 
two cell groups cultured in osteogenic medium (P<0.01), but the transfected cells showed 
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significantly higher levels from day 16 compared to non-transfected cells (P<0.01) (Figure 5 
C).  
  
 
Figure 5: (A) The proliferation characteristics; 
(B) ALP activity; (C) calcium content. 
The bars represent the mean ± SD (n=3). The 
calcium phosphate nanoparticle group (NP)
compared to the group in osteogenic medium 
(O+) * P<0.05, * * P<0.01; NP group compared 
to the group in non-osteogenic medium (O-): #
P<0.05, ## P<0.01. 
SEM observation showed that cells already attached and spread on the surface of Ti-fibers 
after 1 day of seeding, and proliferated along the culture. The rat DPSCs in non-osteogenic 
culture grew faster compared to the two groups from osteogenic culture, and almost 
completely filled the Ti-mesh voids on day 8 (Figure 6 A-C). By day 8, the two cultures in 
osteogenic medium began to produce collagen and to form mineralized nodules. After 24 days 
of incubation, more numerous and larger mineralized globular accretions always associated 
with collagen bundles were observed (Figure 6 D,E).. In the non-osteogenic cell culture, the 
formation of a mineralized extracellular matrix was never observed (Figure 6 F). 
Expression levels of mRNA for ALP, Col I, OC, DSPP and DMP-1 were compared on day 
1, 4, 8 and 16. mRNA expression levels of non-osteogenic cell cultures on day 1, were set as 
baseline controls (relative expression value, 100%). Results showed that ALP was 
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significantly increased in transfected cells (Figure 7 A). Col I showed up-regulation for all 
three groups, and was significant higher in cells cultured in non-osteogenic medium (Figure 7 
B). OC showed some up-regulation at two groups cultured in osteogenic medium at day 8 and 
16, but the transfected cells was significantly higher compared to non-transfected cells at day 
8 (Figure 7 C). The expression of DSPP and DMP-1 revealed significant increase in cells 
cultured in osteogenic medium at day 8 and 16. However, the transfected cells obviously had 
a higher expression levels compared to the non-transfected cells (Figure 7 D,E). 
  
Figure 6: Scanning electron micrographs 
(SEM) of three cell populations on day 8: (A) 
the transfected DPSCs, (B) the DPSCs in 
osteogenic medium, (C) the DPSCs in non-
osteogenic medium; and on day 24: (D) the 
transfected DPSCs, (E) the DPSCs in 
osteogenic medium, (F) the DPSCs in non-
osteogenic medium. 
Figure 7: Representative curves of the mRNA 
levels of ALP (A); collagen type I (B); OC (C); 
DSPP (D); DMP-1 (E); quantified during 16 
days. The bars represent the mean ± SD (n=3). 
The calcium phosphate nanoparticle group 
(NP) compared to the group in osteogenic 
medium (O+) * P<0.05, * * P<0.01; NP group 
compared to the group in non-osteogenic 
medium (O-): # P<0.05, ## P<0.01. 
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4. DISCUSSION 
Effective gene delivery into mammalian somatic cells in vitro and in vivo is an essential 
step in gene therapy. One of the factors that limits the transfection efficiency, is the rapid 
degradation of DNA within the endosomal and lysosomal compartments after endocytosis. In 
this study, we have demonstrated gene transfection efficiency and odonto-stimulatory effect 
in STRO-1-selected rat DPSCs through the pEGFP-BMP2 loaded calcium phosphate 
nanoparticles. 
Calcium ions are known to form ionic complexes with the helical phosphates of DNA, and 
these complexes have easy transportability across the cell membrane via ion-channel 
mediated endocytosis. However, this easy and inexpensive method can not lead to satisfactory 
transfection efficiency in cells, mainly due to low endosomal escape and no protection from 
nuclease degradation.21 Previous studies have reported the method of pDNA encapsulated in 
calcium phosphate nanoparticles as gene carriers, and this amelioration has enhanced the 
transfection efficiency.9,10 Literature shows that 5.88μg of pDNA per mg calciumphosphate 
can be nearly completely loaded in the nanoparticles.9 Using the same ratio, we also acquired 
particles with a size of less than 100 nm. It has been confirmed that particles greater than 200 
nm in diameter are not efficiently taken up by endocytosis and thus only via phagocytosis.22 
One previous study showed that the surface charge of DNA-loaded calcium phosphate 
nanoparticles was positive in neutral aqueous buffer,9 which can result in unmovable 
nanoparticles in  electrophoresis towards the anode. Furthermore, DNA encapsulated calcium 
phosphate particles was protected for the external DNase environment, which was favorable 
for the survive of DNA after endocytosis. 
The endosomal escape as well as nuclear uptake is the final obstacle for of DNA delivery.8 
It has been demonstrated that calcium ions play an important role in endosomal escape, 
cytosolic stability and enhanced nuclear uptake of DNA through nuclear pore complexes.23 
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The inorganic nanoparticles are necessary as DNA carriers for entry into the cell. In our case, 
the DNA doped nanoparticles are non crystalline, in contrast to void calcium phosphate 
nanoparticles.9,10 In the present study, we observed successful gene expression from 
nanoparticle-mediated cells and the gene products were bioactive. As a control, the 
LipofectamineTM reagent showed similar transfection efficiency. However, LipofectamineTM-
mediated cells produced higher hBMP2 levels at day 2 but less at day 8 and 10, compared to 
nanoparticle-mediated group. This difference can be the result of different methods for 
endosomal escape. After endocytosis, lipid-DNA compounds internalize into the endosome 
and initiate the destabilization of the endosomal membrane for escaping.8,24 However, the 
dissolution of inorganic nanoparticles in the acidic endosomal compartment (pH 5.0-5.5) 
results in an osmotic disbalance and the consequent disruption of the endosome so that DNA 
can escape into the cytosol.9 Further, compared to the nanoparticle group, the cells transfected 
with LipofectamineTM showed a lower cell number from day 1 to 8, which can be due to the 
known cytotoxicity of cationic liposomes.25 Altogether, LipofectamineTM was advantageous 
for the transfection efficiency at the beginning of transfection (i.e. at day 2), however after 
that the nanoparticle was superior. 
Titanium fiber mesh is a highly biocompatible material, and its non-degradable nature is 
not necessarily disadvantageous for hard tissue applications. Previous studies already 
demonstrated that titanium fiber mesh, which has been used for bone regeneration,26 
supported the attachment, growth, and differentiation of dental pulp cells in vivo and in 
vitro.19,27 In the current study, the non-osteogenic DPSCs culture demonstrated a faster 
proliferation, due to the inverse relationship between proliferation and differentiation, i.e. 
when cells are more proliferative then the differentiation of the cells is declined, and vice 
versa.28 It is known that BMP-2 in high concentrations can stimulate the early differentiation 
of cells and the formation of extracellular matrix, while not influencing proliferation.29  
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ALP is a prerequisite for the differentiation of dental pulp cells. Compared to previous 
study,19 we observed a prolonged period of ALP activity. Of course a 3-D scaffold provides a 
larger surface area for cell attachment compared to the smooth substrate. This is favorable for 
the spreading and interaction of cells, and thus results in a longer increase of their ALP 
activity.19 Moreover, in our study STRO-1-selected rat DPSCs were used, which were proved 
to show an earlier up-regulation of ALP activity, compared to non-selected rat dental pulp 
cells on a similar scaffold,19 which is due to the more homogeneous cells from STRO-1 
selection.18 The analysis of the ALP activity between the two groups that were cultured in the 
osteogenic medium revealed that the secreted BMP-2 from the nanoparticle-transfected cells 
exerts its effect and accelerates the odontogenic differentiaton and matrix mineralization of 
DPSCs. Previous studies have revealed that BMP-2 functions in a dose-dependent manner. 
High concentrations (i.e. 100 ng/ml) of BMP-2 demonstrated the obvious induction of an 
osteoblastic phenotype.29,30 Our study shows that the transfected cells mediated with 
nanoparticles produce less than 100 ng/ml of hBMP-2, however the transfected cells can 
continuously secrete the Bmp2 gene product into the medium, which may account for similar 
bio-functionality to the higher concentrations necessary with BMP-2 as a protein supplement 
in a single application.31 Furthermore, calcium content measurement demonstrated that the 
transfected cells led to more mineralization, and SEM observation showed many cells were 
fully covered by mineralized deposition. Although a previous study has shown that calcium 
phosphate nanocomposite by themselves can induce cell differentiation and bone formation,32 
we considered that gene products were mostly responsible for cell differentiation, especially 
bearing in mind the low dose calciun phosphate particles used presently. Ideally an empty 
nanoparticle could have been used as negative control. However this was not possible as the 
production of non-DNA loaded particles would have resulted in very different properties 
regarding morphology, composition, and crystallinity. 
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The real-time PCR further confirmed the results mentioned above. It is known that the 
expression of mRNA is always seen prior to the actual protein expression. The mRNA 
expression of ALP also continued to increase, and reached a peak at day 16 for cells in 
osteogenic culture, while the transfected cells demonstrated a more sensitive reaction. 
Collagen type I is the predominant collagen in dentin and bone matrix and the foundation of 
the extracellular matrix on which future mineralization takes place. Higher levels of collagen 
type I mRNA were found in cells from non-osteogenic culture, which agreed with the cell 
growth profiles found through DNA analysis and SEM. OC, a non-collagenous protein, is also 
present in dentin and bone matrix. The mRNA expression of OC showed similar profiles to a 
previous study.19 However, the two groups in osteogenic culture only demonstrated 
differences at day 8. This may be due to the BMP-2, which stimulates the early differentiation 
of cells, while OC is known as a late phase marker for terminal cell differentiation and matrix 
mineralization.33 DSPP is the major part of non-collagenous proteins in natural dentin, and 
plays a crucial role during dentin mineralization.34 DMP-1 is another specific protein in 
dentin, and is a candidate gene for dentinogenesis imperfecta.35 Expression of these mRNAs 
can prove that these cells exhibit odontoblast phenotype.  
 
5. CONCLUSIONS  
Based on our results, we concluded that rat STRO-1 selected dental pulp stem cells can be 
successfully transfected with pEGFP-BMP2 loaded calcium phosphate nanoparticles. A 
relatively high transfection efficacy was achieved, analogous to that of LipofectamineTM. In 
some aspects, this nanoparticle vector was superior to the commercial transfection reagent. 
The secreted BMP-2 reached a functional level and accelerated the odonto-differentiation 
action. Consequently, calcium phosphate nanoparticles can be considered a valid candidate as 
non-viral gene vector. Meanwhile, the established combination of a more homogeneous cell 
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population with gene transfection can be a strategy to improve the efficacy of DPSCs for hard 
tissue engineering. 
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1. SUMMARY AND ADDRESS TO THE AIMS 
Adult stem cells are residing within differentiated tissues or organs, can renew themselves, 
and differentiate into specialized cells. Adult stem cells can be isolated from an individual, 
and thereafter be used for autogenous tissue regeneration, which will eliminate the possibility 
of immune rejection. Furthermore, unlike embryonic stem cells, the use of adult stem cells 
dose not arouse ethical debate. Hence, adult stem cells provide enormous promise for tissue 
engineering applications. 
Recent studies proved the existence of stem cells in postnatal dental pulp tissue. These 
dental pulp stem cells (DPSCs) demonstrated self-renewal capability, and could differentiate 
towards odontoblasts and form a dentin-like structure. However, as a potential candidate for 
dental tissue engineering, the behavior of DPSCs was quite variable, even for cells derived 
from the same source. These results suggest a hierarchy of progenitors in adult dental pulp, 
including a minor population of self-renewing, highly proliferative, multipotent stem cells, 
among a larger compartment of perhaps more committed progenitors. Hence, for successful 
dental tissue engineering strategies, stem cell technology needs to be optimized. Besides cell 
selection, also the addition of growth factors could be an effective strategy. 
Therefore, the aim of this thesis was to isolate this putative DPSC subpopulation from 
postnatal rat dental pulp, and investigate its differentiation potential under both in vitro and in 
vivo environments. Furthermore, bone morphogenetic protein (BMP)-2 gene transfected 
DPSCs were investigated on differentiation characteristics in vitro and in vivo. We addressed 
to the following questions. 
 
1.1 Can a more homogeneous cell subpopulation be sorted from rat dental pulp cells 
using STRO-1 selection? 
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In Chapter two, the STRO-1 antigen, defining a mesenchymal stem cell or progenitor 
subpopulation, was used for separating rat dental pulp cells with fluorescence-activated cell 
sorting (FACS). Subsequently, the STRO-1 positive cells were tested for their ability to 
differentiate towards an odontoblast-like phenotype. Three cell populations (STRO-1 positive, 
STRO-1 negative, and non-sorted cells) were cultured in odontogenic medium containing 
dexamethasone and β-glycerophosphate. Cultures were analyzed by light- and scanning 
electron microscopy (SEM), and assessed for proliferation, ALP activity, and calcium 
content. Results showed that the STRO-1 positive cell population was able to differentiate 
into the odontoblast phenotype, similar to the non-sorted population. The negative cells 
however showed a fibroblast-like phenotype. SEM and real-time PCR confirmed such results. 
In conclusion, the STRO-1 selection proved applicable for rat-derived material, to obtain a 
cell population which is more homogenous. This positive cell fraction was capable of 
differentiating into the odontogenic pathway, whereas the negative fraction was not. 
However, the effect was not always advantageous, when compared to non-sorted cells. 
 
1.2 What is the multilineage potential of STRO-1+ rat dental pulp stem cells in vitro? 
   In chapter three, two cell populations (STRO-1+ and non-sorted cells) were cultured under 
conditions promoting neurogenic, adipogenic, myogenic, and chondrogenic differentiation. 
Results of light microscopy, histochemistry, and immunohistochemistry showed that STRO-
1+ cells were capable to advance into all four differentiation pathways under the influence of 
inductive media. Quantitative PCR and statistical analysis on specific differentiation markers 
confirmed that there were significant up-regulations in STRO-1+ cells compared to the other 
populations during induction culture. On the basis of our results, we concluded that 1) rat 
STRO-1+ dental pulp stem cells were capable of differentiating towards multilineage cell 
types including neural cells, adipocytes, myocytes, and chondrocytes; 2) the STRO-1+ 
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population had a more defined multilineage potential compared to non-sorted cells, probably 
because of its more homologous nature. 
 
1.3 Do STRO-1 selected dental pulp stem cells have the ability for hard tissue formation  
in vivo, when seeded in porous HA/TCP ceramic scaffolds? 
In Chapter four, STRO-1-selected rat dental pulp-derived stem cells were cultured with 
three different media: “BMP-plus” medium containing dexamethasone and 100ng/ml of 
rhBMP-2, “odontogenic” medium containing dexamethasone, and “control” medium without 
supplements. The cell-scaffold complexes were cultured in these media for 1, 4, or 8 days 
before implantation. Histological analysis demonstrated that the cultures with BMP plus and 4 
days of culture gave the highest percentage of hard tissue formation per implant (36 ± 9% of 
pore area). Real-time PCR confirmed these results. In conclusion, STRO-1-selected dental 
pulp stem cells show effectively hard tissue formation in vivo, and a short in vitro culture 
period and addition of BMP-2 can enhance this effect. 
 
1.4 What is the influence of adenoviral-mediated Bmp2 transfection on dental pulp stem 
cells in vitro?  
In Chapter five, STRO-1-selected rat dental pulp-derived stem cells were transfected with 
adenoviral-mediated human bone morphogenetic protein-2 gene (AdBMP-2). Subsequently, 
the cells were evaluated for their odontogenic differentiation ability in medium, not 
containing dexamethasone or other stimuli. Cultures were investigated by light microscopy, 
SEM, and evaluated for cell proliferation, ALP activity and calcium content. Real-time PCR 
was performed for gene expression of Alp, OC, collagen type I, Bsp, Dspp, and Dmp1. 
Finally, an oligo-microarray was used to profile the expression of odontogenesis-related 
genes. Results of ALP, calcium content, and real-time PCR showed that only Bmp2- 
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transfected cells had the ability to differentiate into the odontoblast phenotype, and to produce 
a calcified extracellular matrix. SEM and oligo-microarray confirmed these results. In 
contrast, the non-transfected cells represented a more undifferentiated cell phenotype. Based 
on our results, we concluded that the adenovirus can transfect STRO-1 selected cells with a 
high efficacy. After Bmp2 gene transfection, these cells had the ability to differentiate into 
odontoblast phenotype, even without the addition of odontogenic supplements to the medium. 
 
1.5 How is the in vivo behavior of adenoviral-mediated Bmp2 transfected dental pulp 
stem cells? 
   In Chapter six, the feasibility of hard tissue formation from rat dental pulp-derived stem 
cells transfected with the Bmp2 gene was studied, in an in vivo mouse subcutaneous 
implantation model. STRO-1 selected dental pulp stem cells were transfected with adenoviral-
mediated human bone morphogenetic protein-2 gene (AdBMP-2) and seeded onto a porous 
ceramic scaffold material. The cell-scaffold complexes were cultured in medium not 
containing dexamethasone or other stimuli for 4 days before implantation. Samples were 
retrieved after 1, 4 and 12 weeks and evaluated by histology and real-time PCR. The results 
indicated that only the cultures with Bmp2 gene transfection showed obvious hard tissue 
generation, and 12 weeks of implantation gave the highest percentage of hard tissue formation 
per implant (33 ± 7.3% of pore area). Real-time PCR confirmed these results. In conclusion, 
Bmp2- transfected dental pulp stem cells effectively show hard tissue formation in vivo. 
 
1.6 Can calcium phosphate nanoparticles be applied as a non-viral vector for Bmp2 
transfection into dental pulp stem cells? 
    In Chapter seven, nanoparticles of calcium phosphate encapsulating plasmid DNA 
(pEGFP-BMP2) were prepared. Then, STRO-1-selected rat dental pulp stem cells were 
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transfected using these nanoparticles. The transfection efficiency and bioactivity of the 
secreted BMP2 were examined. Thereafter, the transfected cells were cultured on a fibrous 
titanium mesh. The cultures were investigated by SEM, and evaluated for cell proliferation, 
ALP activity and calcium content. Finally, real-time PCR was performed for odontogenesis-
related gene expression. The results showed that the size of the DNA-loaded particles was 
around 100 nm in diameter. Nanoparticles could protect the DNA encapsulated inside from 
external DNase, and release the loaded DNA in low acidic environment (pH 3.0). In vitro, 
nanoparticle transfection showed a high efficiency analogous to that of LipofectamineTM 
2000. In addition, we found that nanoparticle transfection accelerated or promoted the 
odontogenic differentiation of rat dental pulp stem cells, when cultured in the three 
dimensional scaffolds. Based on our results, pDNA-loaded calcium phosphate nanoparticles 
appears to be an effective non-viral vector for gene delivery, and functioned well for 
odontogenic differentiaton through Bmp2 transfection. 
 
2. CLOSING REMARKS AND FUTURE PERSPECTIVES 
In this thesis, the in vitro and in vivo differentiation potential of STRO-1-selected stem 
cells derived from rat dental pulp was evaluated. All studies focused on two main directions: 
the ability for differentiation towards odontoblast-like cells, and the practical potential for 
hard tissue regeneration. As mentioned in Chapter one, the behavior of DPSCs can vary 
considerably, even for cells from the same source. Only a minor population of DPSC strains, 
derived from single colonies, can generate ectopic dentin in vivo. STRO-1 is the most 
extensively used antibody that appears to recognize stage-and/or lineage-specific stromal 
antigens. The monoclonal antibody STRO-1 reacts with an unidentified cell surface antigen 
expressed by a minor subpopulation of bone marrow stromal cells. Hence, we isolated a 
STRO-1 positive population from dental pulp by fluorescence-activated cell sorting. These 
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cells showed multilineage differentiation potential, and generally were more homologous than 
non-sorted cells. These STRO-1 positive DPSCs also formed abundant hard dentin-like tissue 
after subcutaneous implantation on a ceramic carrier, and thus exhibited great potential for 
therapeutic application.  
Besides cell selection, a second strategy described in this thesis was the transfer of the 
Bmp2 gene into DPSCs. Our studies showed that STRO-1-selected rat dental pulp stem cells 
can be genetically modified with the adenoviral vector containing the hBMP-2 gene. Bmp2-
transfected DPSCs underwent more effective induction toward the odontoblast phenotype, 
and formed abundant hard tissue after subcutaneous implantation on a ceramic carrier, even 
without supplements like dexamethasone. The combination of homogeneously STRO-1 
selected DPSCs with Bmp transfection shows potential to devise new therapies in the future.     
However, the histological results of the current study, revealed only a bone-like hard tissue 
formation, with the absence of typical dentin-like features. Possible explanations are that, 
although the inductive supplements used in dental tissue engineering research are always 
described as “odontogenic”, neither dexamethasone nor BMP-2 are strictly to be defined as 
“odontogenic” factors. Such formulations originated as an osteogenic supplement to promote 
osteoblast differentiation from bone marrow. Furthermore, other possibilities for the absence 
of dentin formation can lie in the micro-morphology and/or chemical characteristics of 
HA/TCP ceramic. To actually progress to potential therapeutic applications for dentin 
regeneration, the development of more suitable stimulating factors, or scaffolds seems 
essential. Improved scaffold designs in composition as well as morphology can facilitate the 
formation of more natural tissue constructs. 
Finally, we also explored the possibility of using plasmid DNA loaded calcium phosphate 
nanoparticles for gene transfection applications. The in vitro results showed that this vector 
can mediate Bmp2 transfection into DPSCs in a highly efficient way, and this accelerated the 
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odontogenic differentiation of DPSCs. However, the in vivo response of this transfection 
lacked hard tissue regeneration, although some odontogenic genes were demonstrated to be 
upregulated. The results of this preliminary study are evidently not in accordance with the in 
vitro study. We assume that, unlike adenovirus, calcium phosphate nanoparticles mediate 
extrinsic gene expression for a shorter period. Thus, the nanoparticle-mediated gene 
transfection scheme needs to be optimized for application in vivo, which will be done in 
follow-up studies.  
The outcomes of these studies are promising, bit still far from applicable. Several problems 
need to be considered before clinical applications can be achieved. 
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1. SAMENVATTING EN EVALUATIE VAN DE DOELSTELLINGEN 
Adulte stamcellen zijn aanwezig in de volledig gedifferentieerde weefsels en organen, 
kunnen zichzelf vernieuwen, en differentiëren tot gespecialiseerde celtypen. Adulte 
stamcellen kunnen geïsoleerd worden vanuit elk individu, en vervolgens gebruikt worden 
voor autogene weefsel regeneratie technieken, zonder kans op immunologische afstoting. 
Verder roept het gebruik van adulte stamcellen geen ethische tweestrijd op, in tegenstelling 
tot het gebruik van embryonale stamcellen. Adulte stamcellen zijn dan ook veelbelovend voor 
toepassing in het veld van de weefselregeneratie.   
Recente studies hebben bewezen dat stamcellen ook aanwezig zijn in het postnatale dentale 
pulpa weefsel. Deze dentale pulp stamcellen (DPSCs) hebben het vermogen tot 
zelfvernieuwing, kunnen differentiëren tot odontoblasten, en vormen een dentine-achtige 
structuur. Belemmeringen voor het gebruik van DPSCs voor dentale weefselregeneratie zijn 
echter dat het gedrag zeer variabel kan zijn, zelfs voor cellen die vanuit een zelfde bron 
gewonnen zijn. Zulke resultaten geven duidelijk aan dat er een zekere hiërarchie van 
voorlopercellen bestaat. In de dentale pulpa is een kleine populatie van zelfvernieuwende, 
snel groeiende, multi-potente stamcellen aanwezig, samen met een grotere hoeveelheid van 
waarschijnlijk meer vastgelegde voorlopercellen. Voor succesvolle tandheelkundige 
weefselregeneratie strategieën lijkt het daarom van belang om stamceltechniek verder te 
optimaliseren. Naast celselectie, kan ook het toevoegen van groeifactoren deel uitmaken van 
zo’n effectieve strategie. 
Het onderliggende doel van dit proefschrift was dan ook de genoemde DPSC subpopulatie 
te isoleren uit de postnatale dentale pulpa van ratten, en vervolgens het differentiatie 
potentiaal van deze populatie te bestuderen, zowel in vitro als in vivo. Vervolgens werden 
DPSCs bestudeerd na transfectie met het gen voor bone morphogenetic protein (BMP)-2. De 
volgende onderzoeksvragen werden gesteld.  
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1.1 Kan een meer homogene subpopulatie van dentale pulpa cellen van ratten verkregen 
worden door middel van STRO-1 selectie? 
In hoofdstuk twee werd het STRO-1 antigen gebruikt om rat dentale pulpa cellen te 
scheiden met behulp van de fluorescence-activated cell sorting (FACS) techniek. STRO-1 
komt tot expressie bij een subpopulatie van mesenchymale stam- of voorloper cellen. 
Vervolgens werden de STRO-1 positieve cellen getest op het vermogen tot differentiatie naar 
een odontoblast-achtig fenotype. Drie celpopulaties (STRO-1 positief, STRO-1 negatief, en 
niet-geselecteerde cellen) werden opgekweekt in odontogeen medium met toevoeging van 
dexamethason en β-glycerolfosfaat. De celkweken werden geanalyseerd met behulp van licht- 
en scanning elektronen microscopie (SEM), en verder beoordeeld op proliferatie, ALP 
activiteit, en hoeveelheid calcium. De resultaten toonden aan dat de STRO-1 positieve 
celpopulatie kon differentiëren tot het odontoblast fenotype, op een vergelijkbare wijze als de 
niet-gesorteerde populatie. De STRO-1 negatieve cellen vertoonden echter een fibroblast-
achtig fenotype. SEM en real-time PCR experimenten bevestigden deze resultaten. In 
conclusie kan gezegd worden dat STRO-1 selectie bruikbaar is om een homogene 
celpopulatie te verkrijgen, zelfs bij materiaal verkregen uit ratten. De positieve cel fractie was 
in staat te differentiëren tot odontoblast, in tegenstelling tot de negatief geselecteerde fractie. 
Echter, de celselectie had niet altijd positief resultaat in vergelijking tot niet gesorteerde 
cellen.  
 
1.2 Kunnen STRO-1+ ratten dentale pulpa stamcellen in celkweek differentiëren tot 
meerdere fenotypen? 
   In hoofdstuk drie werden twee celpopulaties (STRO-1+ en niet-gesorteerde cellen) 
gekweekt onder condities die de differentiatie bevorderen naar een neurogene, adipogene, 
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myogene, of chondrogene ontwikkeling. Resultaten van licht microscopie, histochemie, en 
immunohistochemie lieten zien dat STRO-1+ cellen in staat waren tot ontwikkeling in alle 
vier differentiatie richtingen in de inductieve kweekmedia. Kwantitatieve PCR en statistische 
analyse van specifieke differentiatie markers bevestigde dat STRO-1+ cellen significant beter 
differentieerden ten opzichte van de andere celpopulatie. Op basis van deze resultaten kan 
geconcludeerd worden dat 1) STRO-1+ dentale pulpa stamcellen uit de rat in staat zijn in 
meerdere richtingen te differentiëren inclusief neurale cellen, adipocyten, myocyten, en 
chondrocyten; 2) de STRO-1+ populatie een beter differentiatie potentiaal heeft in vergelijking 
met niet-gesorteerde cellen, waarschijnlijk vanwege de meer homologe aard. 
 
1.3 Kunnen STRO-1 geselecteerde dentale pulpa stamcellen, aangebracht op een poreus 
HA/TCP keramisch dragermateriaal, in vivo hard weefsel vormen ? 
In hoofdstuk vier werden STRO-1-geselecteerde dentale pulpa stamcellen gekweekt in drie 
verschillende media: “BMP-plus” medium met dexamethason en 100ng/ml rhBMP-2, 
“odontogeen” medium met dexamethason, en “controle” medium zonder toevoegingen. De 
cellen werden gezaaid op een dragermateriaal, vervolgens 1, 4, of 8 dagen in deze media 
gekweekt, en daarna geïmplanteerd. Histologische analyse liet zien dat de kweek in 
aanwezigheid van BMP, en met 4 dagen kweektijd, uiteindelijk leidde tot het hoogste 
percentage hard weefsel per implantaat (36 ± 9% van de porie grootte). Real-time PCR 
bevestigde dit resultaat. In conclusie kan gezegd worden dat STRO-1-geselecteerde dentale 
pulpa stamcellen in vivo effectief hard weefsel kunnen vormen, waarbij korte in vitro 
kweektijden en toevoeging van BMP-2 de hard weefsel vorming bevorderen. 
 
1.4 Wat is de invloed van adenovirus-gemedieerde Bmp2 transfectie op dentale pulpa 
stamcellen in vitro?  
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In hoofdstuk vijf werden STRO-1-geselecteerde dentale pulpa stamcellen met behulp van 
een adenovirus getransfecteerd met het gen voor humaan bone morphogenetic protein-2 
(AdBMP-2). Vervolgens werden de cellen geanalyseerd op hun odontogene differentiatie 
capaciteit, in medium zonder dexamethason of andere toevoegingen. De celkweken werden 
onderzocht met behulp van licht microscopie, SEM, en beoordeeld op celproliferatie, ALP 
activiteit en hoeveelheid calcium. Real-time PCR werd gebruikt om de gen expressie van Alp, 
OC, collagen type I, Bsp, Dspp, en Dmp1 te beoordelen. Tenslotte werd een oligo-microarray 
gebruikt om een profiel te maken van de expressie van odontogenese-gerelateerde genen. De 
resultaten van de ALP, calcium, en real-time PCR experimenten lieten zien dat alleen de 
Bmp2-getransfecteerde cellen in staat waren om te differentiëren tot een odontoblast-achtig 
fenotype, en om een gecalcificeerde extracellulaire matrix te vormen. De SEM en oligo-
microarray experimenten bevestigden deze resultaten. De niet-getransfecteerde cellen lieten 
een meer ongedifferentieerd fenotype zien. Op basis van de resultaten kan geconcludeerd 
worden dat adenovirussen STRO-1 geselecteerde cellen met een hoge efficiëntie kunnen 
transfecteren. Na transfectie met het Bmp2 gen, waren de cellen in staat om te differentiëren 
tot een odontoblast-achtig fenotype, zelfs zonder toevoeging van odontogene supplementen 
aan het kweekmedium. 
 
1.5 Hoe gedragen dentale pulpa stamcellen zich in vivo, na adenovirale transfectie met 
Bmp-2 ? 
   In hoofdstuk 6 werd hard weefsel vorming door dentale pulpa stamcellen onderzocht na 
transfectie met het Bmp2 gen, in een subcutaan implantatie model in de muis. STRO-1-
geselecteerde dentale pulpa stamcellen werden getransfecteerd met een adenovirus met het 
humane bone morphogenetic protein-2 gen (AdBMP-2) en daarna uitgezaaid op een poreus 
keramisch dragermateriaal. De cel-dragermateriaal complexen werden opgekweekt in medium 
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zonder toevoeging van dexamethason of andere stimulerende factoren, gedurende 4 dagen. De 
samples 1, 4 en 12 weken na implantatie uitgehaald, en beoordeeld met histologie en real-time 
PCR. De resultaten lieten alleen bij de cellen met Bmp2 gen transfectie duidelijk de vorming 
van hard weefsel zien, waarbij 12 weken implanteren tot het hoogste percentage hard weefsel 
leidde (33 ± 7.3% van de porie grootte). Real-time PCR bevestigde deze resultaten. In 
conclusie kunnen we zeggen dat Bmp2- getransfecteerde dentale pulpa stamcellen effectief 
hard weefsel kunnen vormen in vivo. 
 
1.6 Kunnen calcium fosfaat nanodeeltjes gebruikt worden als een niet-virale vector voor 
Bmp2 transfectie in dentale pulpa stamcellen? 
    In hoofdstuk 7 werden nanodeeltjes van calcium fosfaat gemaakt, met daarin plasmide 
DNA (pEGFP-BMP2). Vervolgens werden STRO-1-geselecteerde dentale pulpa stamcellen 
getransfecteerd met deze nanodeeltjes. Eerst werd de effectiviteit van de transfectie, en de 
bioactiviteit van het afgegeven BMP2 bestudeerd. Daarna werden de getransfecteerde cellen 
gekweekt op titaan vezelgaas. De kweken werden onderzocht met behulp van SEM, en 
beoordeeld op celproliferatie, ALP activiteit en hoeveelheid calcium. Tenslotte werd real-time 
PCR gebruikt om de expressie van odontogenese-gerelateerde genen te onderzoeken. De 
resultaten lieten zien dat de deeltjes geladen met DNA ongeveer 100 nm in diameter waren. 
De nanodeeltjes waren in staat om het gebonden DNA te beschermen tegen extern toegevoegd 
DNase, en konden het DNA vrijgeven in een zure omgeving (pH 3.0). In vitro was transfectie 
met de nanodeeltjes net zo effectief als met LipofectamineTM 2000. Daarnaast werd 
aangetoond dat transfectie met de nanodeeltjes leidde tot een versnelde en verhoogde 
odontogene differentiatie van de dentale pulpa stamcellen op het dragermateriaal. Gebaseerd 
op deze resultaten lijken pDNA-geladen calcium fosfaat nanodeeltjes een effectieve niet-
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virale vector, die voldeed om Bmp2 transfectie en odontogene differentiatie te 
bewerkstelligen. 
 
2. AFSLUITENDE OPMERKINGEN EN TOEKOMSTPERSPECTIEF 
In dit proefschrift werd in vitro en in vivo het differentiatie potentieel geanalyseerd van 
STRO-1-geselecteerde stamcellen verkregen uit de dentale pulpa van de rat. Het onderzoek 
kan verdeeld worden in twee hoofdrichtingen: nl de differentiatie tot odontoblast-achtige 
cellen, en de praktische toepassing voor het regenereren van hard weefsel. Zoals gezegd in 
hoofdstuk 1 is het gedrag van DPSCs erg variabel, zelfs voor cellen die uit een zelfde bron 
verkregen zijn. Slechts een klein deel van DPSC lijnen, afgeleid uit losse kolonies, kan in vivo 
ectopisch dentine vormen. STRO-1 is het meest gebruikte antilichaam dat stadium-en/of 
lijnspecifieke stromale antigenen lijkt te herkennen. Het monoclonale antilichaam STRO-1 
reageert met een nog onbekend antigen op het celoppervlak dat tot expressie komt bij een 
kleine subpopulatie van stromale cellen in het beenmerg. Daarom werd een STRO-1 positieve 
populatie geselecteerd uit dentale pulpa met behulp van fluorescence-activated cell sorting. 
De verkregen cellen hadden het vermogen om naar meerdere fenotypen te differentiëren, en 
waren in het algemeen eenvormiger dan niet gesorteerde cellen. Deze STRO-1 positieve 
DPSCs vormden na subcutane implantatie op een keramisch dragermateriaal een ruime 
hoeveelheid hard dentine-achtig weefsel, en lijken dus in potentie zeer geschikt voor 
therapeutische toepassingen.  
Naast celselectie, wordt er in het proefschrift nog een tweede strategie beschreven, 
namelijk het inbrengen van het gen voor Bmp2 in de DPSCs. Deze studies lieten zien dat 
STRO-1-geselecteerde dentale pulpa stamcellen genetische gemodificeerd kunnen worden 
met een adenovirale vector die het hBMP-2 gen bevatte. Bmp2-getransfecteerde DPSCs 
namen effectiever het odontoblast fenotype aan, en vormden ook na subcutane implantatie op 
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een keramisch dragermateriaal een ruime hoeveelheid hard weefsel, zelfs wanneer geen 
supplementen zoals dexamethason gebruikt werden. De combinatie van de homogene STRO-
1 geselecteerde DPSCs samen met Bmp transfectie lijkt veelbelovend om in de toekomst 
nieuwe therapieën te ontwikkelen.     
De histologische resultaten van alle studies geven echter wel aan dat er een bot-achtig hard 
weefsel wordt gevormd, waarin typische dentine-achtige structuren ontbreken. Een mogelijke 
verklaring hiervoor lijkt te vinden in de supplementen die normaliter gebruikt worden voor 
tandheelkundige weefsel regeneratie. Deze worden weliswaar “odontogeen” genoemd, maar 
strikt gesproken zijn dexamethason noch BMP-2 “odontogene” factoren. Deze factoren zijn 
eigenlijk in eerste instantie beschreven als osteogene supplementen om osteoblast 
differentiatie uit beenmerg te bevorderen. Een andere verklaring voor de afwezigheid van 
dentine vorming zou de micro-morfologie en/of de chemische karakteristiek van het gebruikte 
HA/TCP keramiek kunnen zijn. Om daadwerkelijk tot therapeutische toepassingen voor 
dentine regeneratie te komen, lijkt het essentieel om beter geschikte stimulerende factoren, of 
dragermaterialen te ontwikkelen. Dragermaterialen met een meer geschikte samenstelling en 
morfologie zouden de vorming van meer natuurlijk gelijkende weefsel constructen kunnen 
bevorderen. 
Tenslotte is ook de mogelijkheid onderzocht om calcium fosfaat nanodeeltjes geladen met 
plasmide DNA te gebruiken voor gen transfectie. De resultaten van het in vitro experiment 
lieten zien dat deze vector op een zeer effectieve manier Bmp2 transfectie in DPSCs kan 
mediëren, en dat dit de odontogene differentiatie van de DPSCs versnelde. Echter, in vivo 
leidde deze transfectie methode nog niet tot hard weefsel regeneratie, alhoewel een aantal 
odontogene genen duidelijk hoger tot expressie kwamen. De resultaten van deze preliminaire 
studie zijn duidelijk nog niet in overeenstemming met de in vitro studie. We nemen aan dat de 
calcium fosfaat nanodeeltjes een extrinsieke gen expressie geven gedurende een kortere 
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periode, in vergelijking met het adenovirus. Daarom zal de transfectie methode met de 
nanodeeltjes eerst verder geoptimaliseerd moeten worden voor in vivo gebruik. Hiervoor 
lopen op dit moment al vervolgexperimenten.  
De uitkomsten van alle studies lijken veel belovend, maar zijn nog niet toepasbaar. De 
hierboven genoemde problemen vereisen verdere studie voordat klinische toepassingen 
bewerkstelligd kunnen worden.  
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1. 结论 
成体干细胞是存在于已分化组织或器官中的干细胞。它们既能自我更新，又可分化
成具有特殊功能的细胞。现在越来越多的证据显示，成体干细胞不仅可以分化出其来源
组织或器官的细胞类型，而且还可以跨谱系分化，分化产生与其胚层来源不同的细胞类
型。从个体组织或器官中分离培养的成体干细胞可以用于自体组织再生。自身来源的成
体干细胞不会引起免疫排斥反应，而且避免了应用胚胎干细胞所带来的伦理学争论。因
此，成体干细胞在未来组织工程领域的应用前景非常乐观。 
近来的研究从成体牙髓中分离出了具有自我更新及分化潜能的细胞群，并命名为牙
髓干细胞 (dental pulp stem cells, DPSCs)。牙髓干细胞能够分化为成牙本质细胞，形成牙
髓牙本质样复合体结构。此外，牙髓干细胞也具有多向分化潜能，可以转向分化 (trans-
differentiation) 为脂肪细胞、神经细胞、肌细胞及软骨细胞。同时，牙髓干细胞能够长
期冻存且仍然保持干细胞特性。牙髓成为又一潜在的成体干细胞储库，牙髓干细胞显示
了在牙体组织修复及牙组织工程的应用前景。然而，研究表明不同克隆来源的牙髓干细
胞的生物学行为差异很大，包括增殖能力及体内外分化能力。这一现象提示上述牙髓干
细胞群落间存在异质性 (hierarchy), 仅仅少数细胞亚群为具有高度增殖更新及多向分化潜
能的干细胞，其余大多数群落只是具有一定增殖能力的已经处于定向分化途径上的前体
细胞。这一生物学性状势必影响牙髓干细胞在组织工程的应用前景及效率。因此，为了
成功实施牙组织工程策略，需要优化牙髓干细胞的分离策略。除此之外，生长因子的引
入也不失为有效的手段。 
因此，本论文的目的在于探讨一种可靠的方法，从成体牙髓中分离具有干细胞生物
学活性的 DPSCs 亚群；同时，研究其体内外分化潜能。此外，骨形成蛋白 2（BMP2）
基因被转染引入上述细胞中，观察其体内外分化特点。我们主要致力于以下问题： 
 
1.1 能否通过 STRO-1筛选从大鼠牙髓细胞中获得生物学性状更具同源性的细胞亚群？ 
本论文的第二章主要目的是利用流式分选方法从大鼠牙髓中获得的 STRO-1+ 细胞，
并分析此细胞在体外培养时的分化能力及优势。牙髓细胞源自 Wistar 大鼠切牙牙髓，
与 STRO-1 单克隆抗体进行免疫反应后，使用流式细胞分选 (FACS) STRO-1+/ -细胞并
扩增培养。三组细胞 (STRO-1+/ STRO-1-/未分选的细胞) 在成牙本质诱导培养条件下研
究其在体外的分化能力。通过测定细胞增殖率、碱性磷酸酶 (ALP) 活性及钙含量来观
察细胞的生长模式。利用扫描电镜观察细胞基本形态及形成的矿化结节。并用实时定
 176
                                                                                                                                     Chapter 8 
量 PCR (real-time PCR) 检测成牙本质细胞分化相关基因的表达。诱导后的 STRO-1+ 细
胞能够形成矿化结节，并显著上调相关基因的表达，显示出 STRO-1+ 细胞具有向成牙
本质细胞表型分化的能力。然而，STRO-1- 细胞更多的呈现出成纤维细胞样的表型特
点，没有表现出向成牙本质细胞分化的潜能。未分选的第三代牙髓细胞也有分化的表
现，甚至在诱导培养早期较之 STRO-1+ 细胞还体现一定的优势。 
 
1.2 STRO-1+大鼠牙髓干细胞的体外分化能力如何？ 
本论文的第三章进一步使用成神经性、成脂肪性、成肌性及成软骨性诱导培养体
系分析 STRO-1+细胞多向分化潜能，并比较两组细胞 (STRO-1+/未分选的细胞) 分化潜
能的差异。细胞形态、免疫学和组织化学染色结果表明，在上述四种诱导环境下，
STRO-1+ 细胞能够发生相应的形态学改变，分泌或表达相应细胞分化标志物，显示出
向神经细胞、脂肪细胞、肌细胞及软骨细胞分化的能力。同时，real-time PCR 结果显
示，较之未分选的细胞，STRO-1+ 细胞更显著的上调分化相关基因的表达。基于上述
结果，我们得出结论：1）STRO-1+ 大鼠牙髓干细胞具有多向分化的潜能；2）由于含
有更多同源性的细胞，STRO-1+ 群落表现出更稳定和更确定的分化能力。 
 
1.3 STRO-1分选的牙髓干细胞体内硬组织形成能力如何？ 
本论文的第四章，STRO-1分选的大鼠牙髓干细胞接种于 HA/TCP支架，生长于三
种培养基中：1）“BMP-plus” 培养基，包含地塞米松及 100ng/ml rhBMP-2；2）成牙
本质诱导培养基，包含地塞米松；3）非诱导培养基。细胞－支架复合物于培养的第
1、4 或 8 天移植入免疫缺陷小鼠皮下。组织学分析显示，经过 4 天的移植前培养，能
够在皮下获得最高的异位成骨率 （36 ± 9％）。Real-time PCR 检测从另一方面也验证
上述结果。综上所述，STRO-1 分选的大鼠牙髓干细胞显示出有效的体内硬组织形成能
力。而且，较短的体外培养期及添加 BMP-2能够增强细胞这种效能。 
 
1.4腺病毒介导 Bmp2 基因转染对牙髓干细胞体外分化有何影响？ 
本论文的第五章，该部分研究的主要目的是使用腺病毒载体，介导人 Bmp2基因转
染 STRO-1 分选的大鼠牙髓干细胞，分析转染的功能性效果及对细胞成牙本质能力的
影响。两组细胞 (转染/未转染) 通过细胞增殖率、碱性磷酸酶活性及钙含量的检测来观
察生长状态的改变。利用扫描电镜观察细胞基本形态及形成的矿化结节。通过实时定
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量 PCR检测成牙本质细胞分化相关基因 (碱性磷酸酶、I型胶原、骨钙素、骨唾蛋白、
牙本质唾磷蛋白及牙本质基质蛋白 1) 的表达。另外，使用特异性寡核苷酸微阵列技术
检测两组细胞基因差异表达的情况。碱性磷酸酶活性、钙含量、扫描电镜及 PCR 结果
显示，在非诱导培养基环境中只有转染的细胞有向成牙本质细胞表型分化的能力，而
且能够形成矿化的细胞外基质。寡核苷酸微阵列分析同样也证实了上述的结论。在此
培养环境中，未转染的 STRO-1 分选的大鼠牙髓干细胞则仍然更多的呈现出未分化的
状态。综上所述，腺病毒载体能够高效的转染 STRO-1 分选的大鼠牙髓干细胞。通过
Bmp2 基因的转染，即使在非诱导培养环境下细胞也获得了向成牙本质细胞分化的能力
。基因转染的策略能够赋予干细胞更多的分化能力。 
 
1.5腺病毒介导 Bmp2 基因转染的牙髓干细胞在体内的反应性如何？ 
本论文的第六章，腺病毒载体介导人 Bmp2基因转染 STRO-1分选的大鼠牙髓干细
胞，接种于 HA/TCP 支架。细胞－支架复合物体外培养 4 天后移植入免疫缺陷小鼠皮
下。结果显示，转染后的移植物能够在体内形成明显的骨样硬组织，而且经过 12 周的
移植，能够在皮下获得最高的异位成骨率 （33 ± 7％）。Real-time PCR检测也验证上
述结果。综上所述，通过 Bmp2 基因转染能够显著增强牙髓干细胞体内硬组织形成能
力。 
 
1.6磷酸钙纳米微球能否作为非病毒载体介导 Bmp2基因转染牙髓干细胞？ 
本论文的第七章，该部分研究的主要目的是制备复合质粒 DNA的磷酸钙纳米微球
，评估其相关物化特性。使用此纳米微球作为载体转染大鼠牙髓干细胞，评估转染的
效率及产物的生物学活性。此外，研究转染的大鼠牙髓干细胞在钛纤维三维支架上的
生长特点及分化表现。同时，使用脂质体作为衡量转染效果的对照。结果显示，制备
的负载质粒 DNA 的磷酸钙微球能够达到纳米尺寸，该复合物能够保护包裹的质粒
DNA抵御外界的酶降解作用。纳米微球能够在酸性环境下 (pH 5.0) 逐步释放质粒 DNA
。制备的纳米微球能够转染大鼠牙髓干细胞，并达到同脂质体相近的效率(≈70%)。
ELISA 检测到转染细胞能够分泌功能性水平 hBMP2。通过 W20-17 细胞评估，所分泌
的 hBMP2具有生物学活性。体外三维培养环境下，细胞在钛纤维上生长状态良好，转
染的大鼠牙髓干细胞周围显示更明显的矿化基质沉积，成牙本质细胞分化相关基因的
表达也得到更显著的上调。综上所述，纳米尺寸的负载质粒 DNA的磷酸钙微球能够成
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功转染大鼠牙髓干细胞，此转染系统能够产生功能性的效果。钛纤维支架上，细胞能
够良好的生长，转染后的细胞显示出更明显的向成牙本质细胞分化的能力。负载质粒
DNA的磷酸钙纳米微球能够作为又一有效的非病毒载体，在今后的基因治疗中使用。 
 
2. 结语及对未来的展望 
目前认为，组织工程的目的是从形态结构和功能上修复或再生缺损的组织器官。合适
的细胞资源、生物活性因子及理想的支架材料是组织工程三个基本组成部分。自体组织来
源的成体干细胞具备自我更新及多向分化的能力，更避免了免疫排斥反应，是天然的用于
修复来源组织的组织工程反应细胞。牙髓干细胞的发现为成体干细胞提供了一个新的来源
，也为牙体组织工程提供潜在的最佳选择。 
本研究成功的利用流式分选得到 STRO-1阳性的大鼠牙髓细胞亚群，并研究了细胞在体
内、外增殖及分化的表现。结果证实，STRO-1 阳性筛选得到的细胞具有明显的干细胞特性
；而且，STRO-1 阳性表型细胞的聚集导致细胞同源性更为显著、整体未分化性增加以及对
外界分化刺激更为敏感。此外，细胞显示出较强的体内硬组织形成能力。STRO-1 阳性分选
优化了牙髓干细胞获得途径，提升了组织工程反应细胞的效能。 
通过特定基因的转染能够产生长效的内源性生物活性因子，通过自分泌形成的细胞微
环境进而对细胞生长分化和组织形成产生有效的影响。本研究使用携带 Bmp2基因的腺病毒
载体转染 STRO-1阳性的大鼠牙髓干细胞，在未加其它诱导刺激的环境中能够有效促使细胞
向成牙本质细胞方向分化。体内移植实验显示，转染增强了细胞的硬组织形成能力。STRO-
1分选结合基因转染能够进一步提高牙髓干细胞的分化潜能和实际应用效能。 
作为新的非病毒基因载体，磷酸钙纳米微球技术被尝试用于牙髓干细胞的转染试验。
结果显示，负载 Bmp2基因的磷酸钙纳米微球能够有效地转染细胞，获得相似于商业转染试
剂的效率，而且细胞毒性更低。进而，转染的细胞培养于钛纤维支架上。转染组表现出更
显著的成牙本质细胞分化表型，提示其实际应用价值。 
本研究主要探讨了体外培养的 STRO-1 阳性大鼠牙髓细胞的生物学表现，涉及了
细胞、生物因子和支架三个方面的内容。合适的细胞、合适的因子以及合适的支架能
够模拟出类似天然的组织生长环境，进而提高组织工程方案的成功率和应用效能。本
研究结果提示了牙髓干细胞乐观的应用前景。然而，在真正应用于临床之前，仍有大
量的工作需要完成。 
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